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ABSTRACT 
 
 
ELECTROSPINNING of BIOCOMPATIBLE POLYMERIC 
NANOFIBERS FUNCTIONALIZED with CYCLODEXTRIN 
INCLUSION COMPLEX 
 
Zeynep Aytaç 
M.S. in Materials Science and Nanotechnology 
Supervisor: Assist. Prof. Dr. Tamer Uyar 
August, 2012 
 
Electrospinning is a simple, versatile and cost-effective method to 
produce nanofibers. Electrospun nanofibers have high surface area to volume 
ratio and nanoporous structure. Moreover, electrospun nanofibers could be 
functionalized with additives to extend their application areas. Cyclodextrins 
(CDs) are cyclic oligosaccharides and have truncated-cone shape structure. Due 
to their hydrophobic cavity, CDs have ability to form inclusion complex (IC) 
with a variety of molecule. In our study, we functionalized electrospun 
nanofibers with CDs and CD-ICs.  
In the first part, we successfully produced hydroxypropyl cellulose- 
(HPC), carboxymethyl cellulose- (CMC) and alginate-based nanofibers via 
electrospinning. Then we functionalized these nanofibers with CDs. The 
morphological characterizations of nanofibers were performed through scanning 
electron microscopy (SEM). Here, we have combined the properties of both 
electrospun nanofibers and CDs, and these nanofibers could be used in drug 
delivery, wound healing and tissue engineering applications.  
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In the second part, we prepared IC of sulfisoxazole (SFS) (hydrophobic 
drug) with hydroxypropyl-beta-cyclodextrin (HPβCD) (SFS/HPβCD-IC). Then 
electrospinning of SFS/HPβCD-IC incorporating hydroxypropyl cellulose 
(HPC) nanofibers were performed (SFS/HPβCD-IC-HPC-NFs). In the third part 
of our study, we produced IC of α-tocopherol (α-TC) (antioxidant molecule) 
with beta-cyclodextrin (β-CD) (α-TC/β-CD-IC); and polycaprolactone (PCL) 
nanofibers incorporating α-TC/β-CD-IC was obtained via electrospinning (α-
TC/β-CD-PCL-NFs). In the fourth part, IC of allyl isothiocyanate (AITC) 
(antibacterial compound) with β-CD (AITC/β-CD-IC) was produced. The 
electrospinning of AITC/β-CD-IC incorporating polyvinyl alcohol (PVA) 
nanofibers was carried out (AITC/β-CD-IC-PVA-NFs). In the fifth part, IC of 
quercetin (QU) (antioxidant molecule) with β-CD (QU/β-CD-IC) was prepared; 
and polyacrylic acid (PAA) nanofibers incorporating QU/β-CD-IC was obtained 
via electrospinning (QU/β-CD-IC-PAA-NFs). The structural and thermal 
characterizations of SFS/HPβCD-IC-HPC-NFs, α-TC/β-CD-PCL-NFs, AITC/β-
CD-IC-PVA-NFs and QU/β-CD-IC-PAA-NFs were carried out by scanning 
electron microscopy (SEM), X-ray diffraction (XRD), differential scanning 
calorimetry (DSC) and thermogravimetric analysis (TGA). The amount of 
released molecules were determined via liquid chromatography-mass 
spectroscopy (LC-MS) for SFS/HPβCD-IC-HPC-NFs; high performance liquid 
chromatography (HPLC) for α-TC/β-CD-PCL-NFs and QU/β-CD-IC-PAA-NFs 
and gas chromatography-mass spectrometry (GC-MS) for AITC/β-CD-IC-PVA-
NFs. The antioxidant activity of α-TC/β-CD-PCL-NFs and QU/β-CD-IC-PAA-
NFs was investigated by using 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical 
scavenging assay. Moreover, α-TC/β-CD-PCL-NFs released great proportion of 
α-TC after exposing UV light. Thus, α-TC/β-CD-PCL-NFs exhibited quite high 
photostability. The antibacterial activity of AITC/β-CD-IC-PVA-NFs was 
evaluated by colony counting method against Escherichia coli (E.coli) and 
Staphylococcus aureus (S.aureus). In brief, we concluded that SFS/HPβCD-IC-
HPC-NFs, α-TC/β-CD-PCL-NFs, AITC/β-CD-IC-PVA-NFs and QU/β-CD-IC-
PAA-NFs are promising materials for drug delivery and wound healing 
applications.  
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ÖZET 
 
 
ELEKTROEĞĠRME YÖNTEMĠ ĠLE SĠKLODEKSTRĠN 
ĠNKLÜZYON KOMPLEKSLERĠYLE 
FONKSĠYONLAġTIRILMIġ BĠYOUYUMLU NANOLĠFLERĠN 
ÜRETĠLMESĠ 
 
Zeynep Aytaç 
Yüksek Lisans, Malzeme Bilimi ve Nanoteknoloji Bölümü 
Tez Yöneticisi: Yard. Doç. Dr. Tamer Uyar 
Ağustos, 2012 
 
 
Elektroeğirme nanolif elde etmek için basit, verimli ve maliyeti düĢük bir 
yöntemdir. Elektroeğirme yöntemiyle elde edilen nanolifler yüksek yüzey 
alanına ve nano boyutta gözenekli yapıya sahiptir. Dahası, bu nanolifler 
uygulama alanlarını geniĢletmek amacıyla katkı maddeleri ile fonksiyonel hale 
getirilebilirler. Siklodekstrinler (CD), kesik koni Ģeklindeki siklik 
oligosakkaritlerdir. Hidrofobik kaviteleri sayesinde, pek çok molekülle 
inklüzyon kompleksi (IC) oluĢturabilirler. ÇalıĢmalarımızda, elektroeğirme 
yöntemiyle elde edilen nanolifleri CD ve CD-IC ile fonksiyonel hale getirdik. 
Ġlk kısımda, hidroksipropil selüloz (HPC), karboksimetil selüloz (CMC) 
ve aljinat nanoliflerini elektroeğirme yöntemi ile baĢarıyla ürettik. Daha sonra 
bu nanolifleri CD’lerle fonksiyonel hale getirdik. Bu nanoliflern morfolojik 
karakterizasyonları taramalı electron mikroskobu (SEM) yardımıyla yapıldı. 
Burada, elektroeğirme ile üretilen nanoliflerin ve CD’lerin özelliklerini 
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birleĢtirmiĢ olduk. Bu nanolifler ilaç salımı, yara iyileĢtirme ve doku 
mühendisliği alanlarında kullanılabilirler.  
Ġkinci kısımda, sülfisoksazol (SFS) (hidrofik ilaç) ile hidroksipropil-beta-
siklodekstrin (HPβCD) inklüzyon kompleksini (IC) (SFS/HPβCD-IC) 
hazırladık. Daha sonra SFS/HPβCD-IC içeren hidroksipropil selüloz (HPC) 
nanolifleri elektroeğirme yöntemiyle üretildi. ÇalıĢmamızın üçüncü kısmında, α-
tokoferol (α-TC) (antioksidan madde) ile beta-siklodekstrin (β-CD) IC (α-TC/β-
CD-IC) ürettik; ve α-TC/β-CD-IC içeren polikprolakton (PCL) nanolifleri 
elektroeğirme ile elde edildi (α-TC/β-CD-IC-PCL-NFs). Dördüncü kısımda, alil 
izotiyosiyanat (AITC) (antibakteriyel madde) ile β-CD IC (AITC/β-CD-IC) 
üretildi. AITC/β-CD-IC içeren polivinil alkol (PVA) nanolifleri elektroeğirme  
ile üretildi  (AITC/β-CD-IC-PVA-NFs). BeĢinci kısımda, kuersetin (QU) 
(antioksidan madde) ile β-CD IC (QU/β-CD-IC) hazırlandı ve QU/β-CD-IC 
içeren poliakrilik asit (PAA) nanolifleri elektroeğirme ile elde edildi  (QU/β-
CD-IC-PAA-NFs). SFS/HPβCD-IC-HPC-NFs, α-TC/β-CD-IC-PCL-NFs, 
AITC/β-CD-IC-PVA-NFs ve QU/β-CD-IC-PAA-NFs’nin yapısal ve ısıl 
karakterizasyonları taramalı elektron mikroskobu (SEM), X-ıĢını kırınımı 
(XRD), diferansiyel tarama kalorimetrisi (DSC) ve termogravimetrik analiz 
(TGA) ile yapıldı. Nanoliflerden salınan moleküllerin miktarı SFS/HPβCD-IC-
HPC-NFs için sıvı kromatografisi-kütle spektrometresi (LC-MS); α-TC/β-CD-
IC-PCL-NFs ve QU/β-CD-IC-PAA-NFs için yüksek performanslı sıvı 
kromatografisi (HPLC) ve AITC/β-CD-IC-PVA-NFs için gaz kromatografisi- 
kütle spektrometresi (GC-MS) yardımıyla belirlendi. α-TC/β-CD-IC-PCL-NFs 
ve QU/β-CD-IC-PAA-NFs’nin antioksidan aktivitesi 2 2-difenil-1-pikrilhidrazil 
(DPPH) radikal temizleme testiyle incelendi. Dahası, α-TC/β-CD-PCL-NFs UV 
ıĢığına maruz bırakıldıktan sonra da α-TC’nin büyük bir kısmını salmıĢtır. Bu 
nedenle, α-TC/β-CD-IC-PCL-NFs oldukça yüksek fotostabilite göstermiĢtir. 
AITC/β-CD-IC-PVA-NFs’nin Escherichia coli (E.coli) and Staphylococcus 
aureus’a karĢı antibakteriyel etkisi koloni sayma metoduyla belirlendi. Kısacası, 
SFS/HPβCD-IC-HPC-NFs, α-TC/β-CD-IC-PCL-NFs, AITC/β-CD-IC-PVA-
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NFs ve QU/β-CD-IC-PAA-NFs’nin ilaç salımı ve yara iyileĢtirme 
uygulamalarında gelecek vadeden malzemeler oldukları sonucunda vardık.  
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kontrollü salım. 
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PART I. 
INTRODUCTION 
 
1.1. Electrospinning 
Nanofibers with their porous structure and high surface-to-volume ratio 
are highly promising materials that can be used in various applications. There 
are many methods to produce nanofibers like drawing, template synthesis, phase 
separation, self-assembly, electrospinning, etc. [1].  Among these methods, 
electrospinning is a universal method to produce nanofibers having diameter 
ranging from 10 nanometers to a few microns [2]. In electrospinning, one can 
use polymers, polymer blends, sol-gels and ceramic precursors to obtain 
nanofibers and different structures such as core-shell, hollow, ribbon-like, 
porous and aligned nanofibers can be produced [3]. Electrospinning is superior 
to other methods with its relatively low cost, high production rate and simplicity 
[4]. In addition to unique properties of nanofibers, electrospun nanofibers are 
easily functionalized with nanoparticles, additives, bioactive agents; therefore, 
multifunctional electrospun nanofibers can be produced [5].  
Electrospinning set-up has three main components; these are high voltage 
power supply, syringe pump and grounded collector (Figure 1). The basic 
principle of electrospinning relies on formation of nanofibers through electric 
field. The solution in a syringe is pumped through the outlet of the spinneret at a 
controlled rate by means of syringe pump. At the same time, high voltage in 10-
30 kV range is applied from high voltage power supply; particles within the 
solution are charged and create a repulsive force; this results in deformation of 
drop in cone-shaped named as Taylor cone. When threshold voltage value is 
surpassed, the repulsive force overcomes the surface tension of the solution and 
polymer jet is formed in the tip of spinneret. While aforementioned jet going 
towards the grounded collector, the solvent evaporates and nanofibers are 
collected on the collector [1,4].  
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Figure 1. Schematic view of electrospinning. 
The history of electrospinning dates back to 1900s; electrical charge was 
firstly used to spray liquids by Cooley and his studies was patented in 1902 [6-
8]. Then, Formhals received a patent which is on electrospinning of polymer 
filaments [9]. After almost 40 years, Simm et al. produced nanofibers which 
have diameter below 1μm via electrospinning and this study was patented as 
well [10]. But until 1990s there was no significant study on this technique. In 
early 1990s, Reneker’s group started to study on electrospinning [11-13] and 
this technique has gained reputation. Today it is being used by many research 
groups as well as industries all around the world.  
In regard to parameters of electrospinning, there exist three main groups: 
polymer/solution parameters, processing conditions and environmental 
conditions [1]. In order to obtain uniform nanofibers with electrospinning, one 
should optimize all these parameters. First of all, polymer/solution parameters 
are of vital importance for electrospinning. These are type, molecular weight 
and molecular weight distribution of the polymer; surface tension, dielectric 
constant, conductivity, concentration and viscosity of the solution [1]. Initially, 
molecular weight and concentration are the factors affecting viscosity of the 
polymer solution. Since certain amount of viscosity is required for a polymer 
solution to be electrospun, polymer with suitable molecular weight and 
concentration should be used to obtain electrospun nanofibers. Effect of 
increasing concentration (viscosity) on electrospinning of carboxymethyl 
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cellulose (CMC) was shown in Figure 2. Secondly, as conductivity of the 
solution increases, more charges are formed in the solution, so stretching of the 
solution increases. As a result, nanofibers with a smaller diameter are obtained. 
Thirdly, impact of dielectric constant of the solvent should be considered. While 
the dielectric constant of the solution rises; electrospinnability of solution is 
improved, and diameter of the solutions reduces. Last but not least, surface 
tension has an influence on formation of nanofibers from electrospinning. 
Because in order nanofibers to be formed; surface tension of polymer solution 
must be overcame by electrical forces [1].  
 
Figure 2. Effect of concentration in electrospinning of carboxymethyl cellulose 
(CMC)/polyethyleneoxide (PEO) nanofibers: a) 2.25% CMC-0.75%PEO, b) 3% 
CMC-1%PEO. 
On the other hand, process conditions are of secondary significance in the 
formation of electrospun nanofibers. These are applied voltage, distance from 
tip of the spinneret to collector, feed rate, needle diameter and type of the 
collector [1]. Basically, high voltage is required to produce nanofibers by 
electrospinning. Owing to high voltage, electrostatic force is formed and surface 
tension of polymer is surpassed. In addition, further increase in applied voltage 
cause formation of thinner nanofibers in diameter, because of higher electric 
field caused the higher stretching of solution. On the other hand, decrease in the 
distance from tip of the spinneret to collector lead to increase in electric field; 
thus, average fiber diameter decreases. Mostly, low feed rate is preferred rather 
than high; in order to allow solvent to evaporate. Otherwise, due to the great 
amount of solution fed towards to the collector, nanofibers are most likely to 
4 
 
coalesce on top of another on the collector without finding time to evaporate.  
The needle diameter is another factor influences the morphology and uniformity 
of electrospun nanofibers. First of all, it is important to use suitable needle in 
diameter according to the viscosity of solution. The smaller needle diameter 
leads to formation of small polymer droplet in the tip of the spinneret; therefore 
the surface tension of the so-called droplet is getting higher. So the greater 
amount of voltage and indirectly more time is needed nanofibers to be obtained. 
Finally, the collector is covered with a conductive material such as aluminum 
foil to increase efficiency of nanofibers’ deposition on collector. In addition, 
type of the collector has great contribution to achieve different kinds of 
structures through the use of electrospinning.  For instance, aligned nanofibers 
could be obtained by using rotating collector in electrospinning system [1].  
Lastly, environmental conditions such as temperature, humidity and 
pressure are of importance on the morphology of nanofibers obtained via 
electrospinning [1]. To illustrate, temperature rise triggers viscosity and surface 
tension to decrease; whereas conductivity to increase. So, average fiber diameter 
decreases with the increasing of temperature [14]. On the other side, the rise in 
humidity decelerates the evaporation of solvent; therefore average fiber diameter 
increases. Moreover, porous nanofibrous structure might be formed with the 
increase in the humidity [15]. 
Owing to the unique properties of electrospun nanofibers like high surface 
area to volume ratio, diameters at nanoscale and possibility to produce different 
structures from various materials; electrospun nanofibers can be used in textile 
[5], environmental applications (separation membranes, affinity membranes, 
water filter, air filter) [16]; energy (solar cells, fuel cells, supercapacitors, 
hydrogen storage, optoelectronics, transistor) [16]; defense&security 
(chemical/biological protection and sensor) [3], biomedical applications (tissue 
scaffolds, wound healing materials and delivery of bioactive molecules) [17-18] 
and immobilization of catalysts/enzymes  [5]  (Figure 3). 
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Figure 3. Applications of electrospun nanofibers. 
Electrospun nanofibers in biomedical applications include tissue scaffolds, 
wound healing materials and delivery of bioactive molecules [5,17-18]. Initially, 
in order for a material to be used in biomedical applications; it should have high 
porosity that makes it to be physically similar with extracellular matrix found in 
native tissues and as low as possible fiber diameter (nanoscale range). Therefore 
electrospun nanofibers have ability to fulfill the requirements of biomedical 
materials thanks to its high surface to volume ratio and highly porous structure. 
In addition, above-mentioned unique properties of electrospun nanofibers 
enhance cell attachment, drug loading, and mass transfer properties as well [17]. 
There exist many biocompatible and biodegradable polymers that can be 
electrospun, this variety in polymer types make electrospun nanofibers quite 
applicable for biomedical applications [17]. Moreover, electrospun nanofibers 
6 
 
could be used as wound healing materials especially for burns and abrasions [5]. 
The large surface area to volume ratio and porous structure provide absorption 
of liquid and gases; releasing of the drugs at the same time; whereas protecting 
wounds from bacterial penetration [5,18]. 
1.2. Electrospinning of biopolymers and biodegradable polymers 
In general, polymers are produced from non-renewable materials and not 
biodegradable. This situation has caused environmental problems. In order to 
overcome these problems, there is a gradually increasing interest in biopolymers 
and synthetic biodegradable polymers. Biopolymers are produced by 
microorganisms, plants and animals or synthesized from biological materials 
like amino acids, sugars etc. [19]. They have properties such as biodegradability, 
biocompatibility and sustainability. On the other hand, biopolymers might have 
different molecular weight, degree of substitution, crystallinity etc. In addition, 
it is very difficult to control the properties of them during processing, since 
different conditions should be applied even for different batches of the same 
polymer.  
In principle, biopolymers are divided into three groups: polynucleotides 
(DNA, RNA), polypeptides and polysaccharides (starch, chitin, chitosan, 
cellulose and its derivatives; hyaluronic acid, glycogen, alginate etc.) [20]. 
Polysaccharides consist of several monosaccharide molecules and are linked by 
glycosidic bonds [19]. Cellulose is a kind of polysaccharide that can be 
produced by plant tissues or certain bacteria [19]. It composes of D-anhydro-
glucose repeating units and linked by 1, 4-β-D-glycosidic bridges. It is the most 
common polymer with properties like biodegradability and renewability [20-21]. 
The presence of many hydroxyl groups in the structure leads to formation of 
inter- and intra-hydrogen bonds. Thereby cellulose does not dissolve in common 
solvents [20]. Cellulose has many derivatives like cellulose acetate (CA), ethyl 
cellulose (EC), hydroxypropyl cellulose (HPC), hydroxypropyl methylcellulose 
(HPMC), carboxymethyl cellulose (CMC) etc. These are synthesized by 
substitution of some of the hydroxyl groups of cellulose with another functional 
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group. In general, cellulose derivatives overcome the problem of cellulose 
regarding solubility in common solvents [20].  
Through electrospinning method, various polymers can be used to obtain 
nanofibers. However, usually electrospinning of polysaccharides into nanofibers 
is problematic [22]. The formation of nanofibers from polysaccharides might be 
related with shear thinning property of the polymer and lack of sufficient chain 
entanglement. Initially, in order for a solution to be electrospun into nanofibers 
chain entanglements must be formed before the evaporation of solvent during 
electrospinning process. The formation of entanglement is related with chain 
conformation of polysaccharide. Hence, as compactness of the structure 
increases, fewer entanglements are formed [23]. Secondly, especially anionic 
polysaccharides exhibit shear thinning behavior which results in breaking of the 
polymer jet during electrospinning process and hinders the formation of 
nanofibers [23].  
Biodegradation is the decomposition of a material by environmental means 
such as sunlight, temperature or biological means like bacteria and 
microorganisms [24]. The synthetic polymers like poly (ε-caprolactone) (PCL), 
polyvinyl alcohol (PVA), poly (acrylic acid) (PAA) are classified as 
biodegradable polymers [25]. For instance, PCL is degraded by enzymes or 
lipases of microorganisms [24]. It is linear polyester synthesized from Ɛ-
caprolactone by ring-opening polymerization and it is a hydrophobic polymer. It 
finds application in pharmacy and agriculture areas [25]. On the other side, PVA 
is a hydrophilic polymer and synthesized by hydrolysis acetate groups of poly 
(vinyl acetate). It is widely used polymer in paper processing, textile sizing, 
ﬁnishing adhesives and binders [25]. PAA is a hydrophilic polymer and 
synthesized from acrylic acid. 
Many groups have produced PCL nanofibers by electrospinning. In these 
studies various solvent systems were used such as: chloroform, 
chloroform/methanol,  chloroform /acetone, chloroform/ethanol, chloroform/ 
dimethylformamide (DMF), dichloromethane (DCM), DCM/DMF, 
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DCM/methanol, acetone, trifluoroethanol (TFE) , TFE/water, DMF/ 
tetrahydrofuran (THF), glacial acetic acid, 90% acetic acid, glacial formic acid, 
formic acid/acetone [26-27]. There are drug delivery studies of electrospun PCL 
nanofibers in the literature [28-31]. PVA is commonly used polymer in 
electrospinning method and it is generally dissolved in water to be electrospun.  
In the literature, there exist studies regarding drug delivery applications of 
electrospun PVA nanofibers [32-35].  Electrospinning of PAA was also studied 
for drug delivery applications [36-37].  
1.3. Cyclodextrins 
Cyclodextrins (CDs) are cyclic oligosaccharides and linked by α-(1,4) 
glucopyranose units [38-39]. The native CDs are (alpha-cyclodextrin) (α-CD), 
beta-cyclodextrin (β-CD), gamma-cyclodextrin (γ-CD) with 6, 7, 8 
glucopyranose units, respectively. The height of cavity in three native CDs is the 
same but cavity volume; outer diameter and cavity diameter gradually increases 
from α-CD to γ-CD [38] (Figure 4). The main properties of α-CD, β-CD, and γ-
CD are shown in Table 1. The solubility of native CDs differs from each other 
due to the hydrogen bond formation between C-2-OH groups and C-3-OH 
groups of neighboring glucopyranose units. Thus, complete secondary belt is 
formed by these hydrogen bonds. As α-CD is only able to form four hydrogen 
bonds instead of six and γ-CD has a non-coplanar and flexible structure; these 
two CDs are much more soluble in water as compared to β-CD [39]. β-CD is the 
least water soluble among three native CDs because of its rigid structure. 
Moreover, several CD derivatives such as methyl-β-CD, hydroxypropyl β-CD, 
hydroxypropyl γ-CD, sulfobutylated β-CD were synthesized by substitution of 
primary and secondary hydroxyl groups of the cyclodextrins to improve the 
safety and solubility of CDs. CD derivatives might have different cavity volume, 
solubility, stability against light or oxygen than their parent CDs [38]. CDs are 
synthesized by degradation of starch with the help of glucosyl transferase 
enzyme (CGTase) produced by several microorganisms such as bacillus 
macerans, klebsiella oxytoca, bacillus circulans and alkalophylic bacillus [39].  
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Figure 4. Schematic views and chemical structures of α-CD, β-CD, γ-CD. 
 
Table 1. General properties of cyclodextrins [39].  
Properties α-cyclodextrin β-cyclodextrin γ-cyclodextrin 
Number of glucopyranose units 6 7 8 
Molecular weight (g/mol) 972 1135 1297 
Solubility in water at 25 oC (g/100 mL) 14.5 1.85 23.2 
Outer diameter (Å) 14.6 15.4 17.5 
Cavity diameter (Å) 5.7 7.8 9.5 
Height of torus (Å) 7.9 7.9 7.9 
Approximate cavity volume (Å3) 174 262 427 
 
The secondary hydroxyl groups of CDs are located in one edge of the ring; 
whereas primary hydroxyl groups are in the other edge. As the free rotation 
ability of primary hydroxyl groups lead to smaller diameter of the cavity in that 
edge; the diameter of the two edges of the ring is not same. So, CDs have 
truncated cone shape structure [39].  In addition, apolar hydrogens and ether-like 
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oxygens are situated inside the truncated cone shape molecule. Therefore, CDs 
have relatively hydrophobic cavity [38]. Owing to this cavity, CDs are able to 
form host-guest interactions, that is inclusion complexes with various solid, 
liquid, gaseous molecules [38].  
CDs (host) form inclusion complexes with guest molecules in appropriate 
polarity and dimension (Figure 5). The main driving force of the inclusion 
complexation is substitution of water molecules inside the cavity by 
hydrophobic guest molecule. Since in the apolar cavity of CDs there are slightly 
apolar water molecules with high entalpy; so the addition of apolar 
(hydrophobic) guest molecule gave rise to the replacement of high entalpy water 
molecules with the guest molecule [38]. Thereby, apolar-apolar association is 
formed and more stable energy state is achieved with the decrease of CD ring 
strain [68]. The inclusion complex is a dynamic process and neither covalent 
bonds are broken nor new covalent bonds are formed [38]. There are many 
advantages that inclusion complex have over the pure guest molecule for 
instance, higher solubility of hydrophobic guests, higher thermal stability, 
control of volatility and sublimation, masking off unpleasant odors, and 
controlled release of drugs and flavors [38]. 
 
Figure 5. Schematic view of inclusion complex formation between CD and 
guest molecule.   
CDs are widely used in analytical chemistry; food, cosmetic, 
pharmaceutical, chemical, textile and paper industries; also in pesticides, 
flavors, adhesives and coatings [38-40]. In pharmaceutical industry in which 
drugs are sparingly soluble in water, CDs are of vital importance. The 
conventional drug formulation systems are not enough to attain drug 
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formulations without adverse effects and irritation. However, CDs increase 
solubility, enhance stability, improve bioavailability, reduce dose and volatility 
of the so-called drugs and masking the unpleasant odors and bitter tastes 
[38,40].  
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PART II. 
CHAPTER I. ELECTROSPINNING of POLYSACCHARIDES 
FUNCTIONALIZED with CYCLODEXTRINS 
 
2.1. General Information 
Polysaccharides are one of the main groups of biopolymers [19-20]. 
Several monosaccharide molecules linked by glycosidic bonds and form 
polysaccharides [19]. Electrospinning is a cost-effective, simple and versatile 
technique to produce nanofibers [20]. But electrospinning of polysaccharides is 
difficult. Because they are not able to form sufficient chain entanglement which 
is of great importance in the formation of nanofibers and they show shear 
thinning behavior which is not favorable for formation of nanofibers [23]. 
Cellulose is a kind of polysaccharide and produced by plant tissues or certain 
bacteria [19]. Each glucose unit in the structure has three hydroxyl groups. Due 
to the presence of these hydroxyl groups, cellulose forms inter- and intra-
hydrogen bonds that restricts its solubility in common solvents [20-21]. 
Cellulose derivatives which can be dissolved in common solvents are produced 
by substitution of certain hydroxyl groups of cellulose with another functional 
group [20]. 
Hydroxypropyl cellulose (HPC) is a non-ionic cellulose derivative. It is 
obtained by substitution of some hydroxyl groups of cellulose to hydroxypropyl 
groups [22] (Figure 6). It is water soluble, biodegradable polymer and widely 
used in food, pharmaceutical industries; and tissue engineering [41-43]. 
Electrospun HPC nanofibers could be quite applicable owing to the unique 
properties of electrospun nanofibers like high surface area and nanoporous 
structure. However, there are a few studies concerning electrospinning of HPC 
[44-45]. One of them was carried out by Shukla et al. They have produced HPC 
nanofibers in ethanol and 2-propanol [44]. In another study, Francis et al. 
obtained HPC nanofibers in aqueous solution with the help of polyethylene 
oxide (PEO) [45]. 
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n
R=H or R=CH2CH(OH)CH3  
Figure 6. Chemical structure of HPC. 
Carboxymethyl cellulose (CMC) is anionic cellulose derivative and 
synthesized by replacing certain amount of hydroxyl groups with carboxymetyl 
groups (Figure 7) [22]. CMC is used in pharmaceutical applications; textile, 
paper, food and cosmetic industries [19]. It is very difficult for CMC to be 
produced as nanofibers due to its inability to form a jet in aqueous solution [23]. 
That's why there are a few studies in the literature on electrospinning of CMC 
[46-48]. In previous studies concerning electrospinning of CMC, Frenot et al. 
investigated the effect of molecular weight (Mw), degree of substitution, and 
substitution pattern of CMC on electrospinning of CMC/PEO blend in aqueous 
solution. They deduced that substitution pattern of CMC is of vital importance 
on the morphology of electrospun nanofibers [46]. Aluminum nanoparticles 
containing carboxymethyl cellulose nitrate composite nanofibers were produced 
via electrospinning by Long et al. [47]. In another study, silver nanoparticles 
were deposited on electrospun cellulosic (cellulose, cellulose acetate, 
carboxymethyl cellulose) nanofibers [48].  
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n
R=H or R=CH2CO2H  
Figure 7. Chemical structure of CMC. 
Alginate is an anionic polysaccharide that is obtained from marine brown 
algae. It is a copolymer composed of β-1, 4-D-mannuronic acid (M) and α-1, 4-
L-glucuronic acid (G) units (Figure 8). The repeating units (M and G) are 
arranged in different proportions and sequences of homopolymer blocks (MM or 
GG) and alternating blocks (MG) [49]. Alginate is widely used polymer in 
cosmetic industry, food industry as additive and in biomedical applications such 
as wound dressing, tissue engineering scaffold, and drug delivery carrier [49]. 
On the other hand, electrospinning of alginate from its aqueous solution is still a 
challenge. Because of its rigid conformation that does not allow chain 
entanglement formation [50]. In order to overcome this problem, alginate was 
used in mixture with polymers like polyethylene oxide (PEO) [51-64], polyvinyl 
alcohol (PVA) [53, 65-68] except two studies [50, 69]. Nie et al. attained to 
produce sodium alginate nanofibers in aqueous solution with the help of 
glycerol [50]. Sodium alginate nanofibers were obtained in N, N-
dimethylformamide (DMF) with the addition of Ca
2+ 
cations by Fang et al [69]. 
n
m
 
Figure 8. Chemical structure of alginate. 
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Cyclodextrins (CDs) are cyclic oligosaccharides and linked by α-(1,4) 
glucopyranose units. They have truncated-cone shape structure. Owing to their 
hydrophobic cavity, they are able to form host-guest interactions (inclusion 
complex) with a variety of solid, liquid, gaseous molecule in appropriate 
polarity and dimension [39]. They might be used in functionalization of 
nanofibers for different applications like filtration [70-74] and active food 
packaging [75-76]. 
In this study, electrospinning of HPC- CMC- and alginate-based 
nanofibers were successfully produced. Then these nanofibers were 
functionalized with modified CDs (hydroxypropyl-beta-cyclodextrin (HPβ-CD), 
methyl-beta-cyclodextrin (Mβ-CD), hydroxypropyl-gamma-cyclodextrin (HPγ-
CD). Moreover, improvement was observed in the electrospinnability of CD 
functionalized nanofibers with the addition of CDs. The morphology of 
electrospun nanofibers were examined by scanning electron microscopy (SEM); 
whereas viscosity and conductivity of prepared solutions were measured by 
viscometer and conductivity meter.  
2.2. Materials 
Hydroxypropyl cellulose (HPC, Mw ~300.000 g/mol, Scientific polymer 
products), cellulose carboxyl methyl sodium salt (400-800 cp, Scientific 
polymer products), alginic acid sodium salt (30cp, Scientific polymer products), 
polyethylene oxide (PEO, Mv ~ 900.000 g/mol, Sigma aldrich); hydroxypropyl-
beta-cyclodextrin (HPβ-CD), methyl-beta-cyclodextrin (Mβ-CD), 
hydroxypropyl-gamma-cyclodextrin (HPγ-CD) (Wacker chemie AG, Germany), 
ethanol (Sigma aldrich, ≥99.8%), 2-propanol (Sigma aldrich, ≥99.5%), Triton 
X-100 (Sigma aldrich) were purchased and used without any purification. The 
water was distilled from a Millipore Milli-Q Ultrapure Water System. 
2.3. Electrospinning unit at UNAM 
  Electrospinning unit at UNAM is composed of syringe pump (Model: SP 
101IZ, WPI), high voltage power supply (Matsusada Precision, AU Series, 
Japan), and grounded collector and these are located in Plexiglas box (Figure 9). 
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The syringe is placed horizontally on syringe pump and electric field is supplied 
from high voltage power supply. Electrospun nanofibers are collected on a 
grounded cylindrical metal collector that is covered by aluminum foil. 
Temperature and relative humidity inside the Plexiglas box are measured by 
thermo-hygrometer (Honeywell, TM0005-X). 
 
 
Figure 9. Electrospinning unit at UNAM: a) syringe pump, b) high voltage 
supply, and c) collector. 
2.4. Production of electrospun nanofibers 
HPC was dissolved in various solvent systems (water, ethanol/water, 
ethanol, ethanol/ 2-propanol) and solutions were stirred overnight at room 
temperature. While preparing solutions containing Triton X-100 (1% (w/v)), 
HPC was dissolved in water and then Triton X-100 was added immediately after 
the addition of solvent and stirred overnight at room temperature. With respect 
to CD including solutions, CDs (HPβ-CD, Mβ-CD, and HPγ-CD) was put in 
polymer solution after 12 hours stirring of HPC dissolved in ethanol and the 
solution was stirred 6 hours more. Finally, HPC solutions was loaded into 3 ml 
plastic syringe with a needle inner diameter of 0,7 mm or 0,8 mm placed 
horizontally on the pump and was sent towards to collector at a rate varies 
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between 0.5ml/h to1ml/h. A voltage ranging from 15-19 kV was obtained from 
a high voltage power supply. Cylindrical metal covered by aluminum foil was 
used as a collector. Distance between needle tip and collector is between 7 cm to 
15 cm. Experiments were performed at 22-24°C, 20-32 % humidity. 
CMC was dissolved in water and stirred at room temperature overnight. 
For Triton X-100 containing solutions, Triton X-100 (1% (w/v)) was added 
immediately after the addition of solvent and solutions stirred at room 
temperature overnight. For CMC/PEO blend solutions; firstly, CMC was 
dissolved in water. After solvation of CMC, PEO was put in and solution was 
stirred at room temperature overnight. As regards to CD including solutions, 
CMC and PEO was dissolved in water and the solution was stirred at room 
temperature overnight. Then CDs (HPβ-CD, Mβ-CD, and HPγ-CD) was put in 
polymer solution and stirred 6 hours more. Lastly, CMC solutions was loaded 
into a 3 ml plastic syringe with a needle inner diameter of 0,8 mm placed 
horizontally on the pump and was sent towards to collector at a rate 1ml/h. A 
voltage ranging from 15-17 kV was obtained from a high voltage power supply. 
Cylindrical metal covered by aluminum foil was used as a collector. Distance 
between needle tip and collector is 10 cm. Experiments were performed at 21-
25°C, 25-41% humidity. 
Alginate was dissolved in water and stirred at room temperature overnight. 
While preparing blend solutions with alginate and PEO; initially, alginate was 
dissolved in water. Afterwards PEO and Triton X-100 (1% (w/v)) was added 
and stirred at room temperature overnight. For CD including solutions, alginate, 
PEO and Triton X-100 (1% (w/v)) was dissolved in water and stirred at room 
temperature overnight. Then CDs (HPβ-CD, Mβ-CD) were put in polymer 
solution and the solution was stirred 6 hours more. In the end, alginate solutions 
was loaded into a 3 ml plastic syringe with a needle inner diameter of 0,7 or 0,8 
mm placed horizontally on the pump and was sent towards to collector at a rate 
1ml/h. A voltage ranging from 15-17.5 kV was obtained from a high voltage 
power supply. Cylindrical metal covered by aluminum foil was used as a 
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collector. Distance between needle tip and collector is between 10 cm to 12 cm. 
Experiments were performed at 21-22°C, 22-44% humidity. 
2.5. Measurements and characterization techniques 
The viscosity of HPC solutions were determined by Brookfield 
Viscometer DV-II+ Pro; whereas those of CMC solutions were investigated at a 
constant shear rate of a 100 1/sec at 22°C by Anton Paar Physica MCR 301 
rheometer equipped with a spindle CP 40-2°C. The conductivity of both HPC 
and CMC solutions were measured with Multiparameter meter InoLab® Multi 
720 (WTW) at room temperature.  
The morphologies and average fiber diameter (AFD) of electrospun 
nanoﬁbers were examined by SEM (FEI – Quanta 200 FEG). Samples were 
coated 6 nm Au/Pd before taking SEM images. In order to calculate AFD, 
around 100 fibers were analyzed. 
2.6. Results and discussion 
2.6.1. Electrospinning of CD functionalized HPC nanofibers 
Electrospinning of HPC is quite difficult in aqueous solution because of 
its rigid structure that prevents formation of chain entanglement [23]. 
Nevertheless, we initially dissolved HPC polymer in aqueous solution at 
different concentrations (1%, 2%, 3%, 4%, 5%, 7%, 9% (w/v)) and tried to 
electrospin these solutions. But we observed splashes rather than nanofibers. 
SEM image of 3% (w/v) HPC solution was shown in Figure 10a. The formation 
of beads may be due to the capillary breakup of the spinning jet by high surface 
tension [1]. So, we thought that reducing the surface tension of the solution may 
support the formation of fibers without beads. Therefore, we added a nonionic 
surfactant (Triton X-100) to polymer solution. Surfactants make easier the 
spinning of a polymer solution by reducing the surface tension; and more 
uniform nanofibers are obtained [1]. However, in this study we did not observe 
nanofiber formation from HPC solutions with the addition of Triton X-100 
(Figure 10b, 10c, 10d).   
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Figure 10. SEM images of electrospun (a) 3% (w/v) HPC; (b) 3% (w/v) HPC 
and 1% (w/v) Triton X-100, (c) 3.5% (w/v) HPC and 1% (w/v) Triton X-100, 
(d) 4% (w/v) HPC and 1% (w/v) Triton X-100 solutions in aqueous solution. 
Moreover, we changed the solvent system to have bead-free HPC 
nanofibers. As seen in Figure 11a, the morphology has changed from completely 
beaded structure to beaded nanofibers by adding ethanol to solvent system. We 
also dissolved HPC polymer in ethanol (100%) and ethanol:2-propanol (1:1). As 
a result, we attained to produce bead-free nanofibers (Figure 11b, 11c). This 
might be related with lower surface tension of ethanol and 2-propanol compared 
to water [1]. This result was consistent with the study of Shukla et al. in the 
literature [44]. 
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Figure 11. SEM images of electrospun HPC (3% (w/v)) nanofibers: (a) in 
ethanol/water (1:1), (b) in ethanol, (c) in ethanol/2-propanol (1:1).  
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We functionalized electrospun HPC nanofibers with CDs. Therefore, we 
may increase the application of HPC for drug delivery and biomedical 
applications. Because we have combined high surface area and nanoporous 
structure of electrospun nanofibers, and inclusion complexation ability of CDs 
with various molecules such as unpleasant odors and organic wastes. Three 
different modified CD types (HPβ-CD, Mβ-CD, and HPγ-CD) with three 
different 25%, 50%, 100 % (w/w) proportions were used to produce functional 
electrospun HPC nanofibers. According to SEM images displayed in Figure 
12a-i, all fibers were bead-free and uniform.  
5 μm
10 μm
5 μm 5 μm
5 μm 5 μm 5 μm
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Figure 12. SEM images of electrospun HPC (3% (w/v)) nanofibers incorporated 
(a) 25% (w/w) HPβ-CD, (b) 50% (w/w) HPβ-CD, (c) 100% (w/w) HPβ-CD; (d) 
25% (w/w) Mβ-CD, (e) 50% (w/w) Mβ-CD, (f) 100% (w/w) Mβ-CD; (g) 25% 
(w/w) HPγ-CD, (h) 50% (w/w) HPγ-CD, (i) 100% (w/w)HPγ-CD in ethanol.  
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Viscosity and conductivity measurements were also performed for HPC 
solutions to investigate their effect on AFD (Table 2). We successfully produced 
HPC nanofibers which have 150±65 nm diameter. On the other side, AFD of 
HPβ-CD functionalized HPC nanofibers are lower than electrospun HPC 
nanofibers. Thus, 25%, 50%, 100 % (w/w) HPβ-CD including HPC nanofibers 
have 115±40 nm, 100±40 nm and 70±35 nm, respectively. This might be due to 
much higher conductivity and lower viscosity of these solutions. Moreover; as 
the amount of HPβ-CD increases, the AFD is getting lower. The higher 
conductivity was the main reason for this situation. AFD of 25%, 50%, 100 % 
(w/w) Mβ-CD containing HPC nanofibers are 65±25 nm, 65±30 nm and 55±25 
nm respectively. This is also related with extremely higher conductivity and 
lower viscosity than that of electrospun HPC nanofibers. Lastly, HPγ-CD 
functionalized HPC nanofibers with 25% (w/w) and have 50% (w/w) HPγ-CD 
have a little bit higher conductivity and lower viscosity as compared to 
electrospun HPC nanofibers. That’s why they were only about 30 nm smaller in 
diameter than electrospun HPC nanofibers. On the other hand, as 100% (w/w) 
HPγ-CD containing HPC nanofibers has a little bit lower conductivity than 
electrospun HPC nanofibers, average fiber diameter is higher than electrospun 
HPC nanofibers.  
Table 2. The characteristics of HPC solution and CD incorporated HPC 
solutions and the resulting electrospun ﬁbers. 
Solutions 
Conductivity 
(μS/cm) 
Viscosity (Pa.s) Diameter (nm) Fiber morphology 
HPC3 4.35 0.207 150±65 beaded nanofibers 
HPC3/HPβ-CD25 13.90 0.068 115±40 bead-free nanofibers 
HPC3/HPβ-CD50 23.60 0.104 100±40 bead-free nanofibers 
HPC3/HPβ-CD100 37.70 0.133 70±35 bead-free nanofibers 
HPC3/MβCD25 34.00 0.084 65±25 bead-free nanofibers 
HPC3/MβCD50 63.40 0.088 65±30 bead-free nanofibers 
HPC3/MβCD100 110.00 0.123 55±25 bead-free nanofibers 
HPC3/HPγCD25 4.71 0.096 120±50 bead-free nanofibers 
22 
 
HPC3/HPγCD50 4.65 0.084 120±55 bead-free nanofibers 
HPC3/HPγCD100 4.16 0.131 205±80 bead-free nanofibers 
 
2.6.2. Electrospinning of CD functionalized CMC nanofibers 
CMC has rigid structure and high surface tension that prevent chain 
entanglement among the chains.  Therefore electrospinning of CMC is still 
challenging [23].  Nonetheless, we prepared 1% (w/v) CMC solution in aqueous 
solution and observed only splashes on collector. Since higher viscosity favors 
formation of nanofibers without beads, concentration of the solution was 
increased up to 7% (w/v) in order to obtain bead-free nanofibers. But we could 
not obtain bead-free nanofibers. The solution with 7% (w/v) CMC was not 
possible to pass through the needle. This probably related with high viscosity of 
the solution. On the other hand, formation of splashes may due to the capillary 
breakup of the spinning jet by high surface tension. So, we thought that reducing 
the surface tension of the solution may support the formation of fibers without 
beads [1]. That’s why, a nonionic surfactant (1% (w/v) Triton X-100) was added 
into CMC solutions, but again splashes were seen on the collector. We inferred 
from these results that reducing surface tension of solution is not adequate to 
electrospin CMC solution into nanofibers.  
Another way to electrospin CMC could be blending it with other polymers 
such as PEO and PVA that enable CMC to be electrospun. CMC is a rigid 
structure with its compact chain conformation [3]. On the other side, with the 
addition of PEO; it breaks the hydrogen bonds among CMC chains and form 
new hydrogen bonds. So viscosity was getting higher due to the newly created 
hydrogen bonds as shown in Table 3. In general, electrospinnability of CMC is 
increasing with the increasing ratio of PEO [11]. We combined CMC with PEO 
at different ratios (1:1, 3:1) and total concentrations (2%, 3%, 4% (w/v)) (Figure 
13, Figure 14). Figure 13 showed SEM images of CMC/PEO blended at a ratio 
of 1:1 at different total concentrations (2%, 3%, 4% (w/v)). When total polymer 
concentration was 2% (w/v), only beads were observed (Figure 13a). As we 
increased total polymer concentration to 3% (w/v), we obtained beaded 
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nanofibers (Figure 13b). Finally, if we electrospin the solution having 4% (w/v) 
total polymer concentration, we successfully electrospun bead-free nanofibers 
(Figure 13c). 
5 μm 10 μm5 μma. b. c.
 
Figure 13. SEM images of electrospun CMC/PEO solutions at 1:1 ratio with 
different total polymer concentrations: (a) 2%, (b) 3%, (c) 4% (w/v). 
Then, we increased the proportion of CMC in the mixture. Figure 14 
showed SEM images of CMC/PEO blended at a ratio of 3:1 at different total 
concentrations (2%, 3%, 4% (w/v)). Similarly, we could not achieve to produce 
bead-free nanofibers with 2% (w/v) (Figure 14a) and 3% (w/v) (Figure 14b) 
total polymer concentrations. Lastly, we electrospun CMC/PEO with 4% (w/v) 
total polymer concentration and only few beads were observed in SEM images 
(Figure 14c).  
3 μm 3 μm 2 μma. b. c.
 
Figure 14. SEM images of electrospun CMC/PEO solutions at 3:1 ratio with 
different total polymer concentrations: (a) 2%, (b) 3%, (c) 4% (w/v).  
On the other hand, CMC based nanofibers were functionalized with 
modified (HPβ-CD, Mβ-CD, HPγ-CD) CDs in various proportions (25%, 50%, 
100% (w/w)). These nanofibers could be used for biomedical applications. Since 
they have both unique properties of electrospun nanofibers and inclusion 
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complex formation capability of CDs. SEM images of above mentioned 
nanofibers were shown in Figure 15a-i. As it is seen, there was no bead on CD 
functionalized CMC nanofibers. Therefore, we can easily conclude that the 
addition of CD eliminates formation of the beads in the structure.  
4 μma. 4 μmb. 5 μmc.
4 μmd. 3 μme. 5 μmf.
3 μmh. 5 μmi.g. 3 μm
 
Figure 15. SEM images of electrospun CMC/PEO (3:1) nanofibers incorporated 
(a) 25% (w/w) HPβ-CD, (b) 50% (w/w) HPβ-CD, (c) 100% (w/w) HPβ-CD; (d) 
25% (w/w) Mβ-CD, (e) 50% (w/w) Mβ-CD, (f) 100% (w/w) Mβ-CD; (g) 25% 
(w/w) HPγ-CD, (h) 50% (w/w) HPγ-CD, (i) 100% (w/w) HPγ-CD in aqueous 
solution.  
The effect of viscosity and conductivity on the morphology and AFD of 
CD functionalized CMC nanofibers were investigated as well (Table 3). The 
addition of CD caused viscosity of all of the CMC/PEO/CD solutions to 
increase compared with solution without CD. Increasing viscosity might be due 
to the chain entanglement formation among the CMC chains. That’s why 
electrospinnability of almost bead-free CMC/PEO nanofibers with a high ratio 
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of CMC is possible with the addition of CDs. The other property affecting the 
morphology of electrospun nanofibers is the conductivity of the solutions. 
Higher conductivity facilitates the production of bead-free ﬁbers owing to the 
higher stretching of solution under high electrical field [1]. The conductivity of 
solutions containing CD was higher than solutions without CD, thus the beads 
were eliminated in the structure. Therefore the viscosity and conductivity are of 
crucial importance for the production of bead-free electrospun nanofibers. 
Moreover, we calculated AFDs of nanofibers functionalized with CDs. During 
electrospinning more viscous solutions exhibit greater resistance to stretching, 
so thicker fibers are formed when the viscosity of solution is higher [1]. In 
general, the AFD was higher in nanofibers functionalized with CDs due to the 
higher viscosity of solutions than solutions without CD. Also increasing amount 
of CD usually resulted in thicker fibers. On the other hand, the conductivity 
values of CD containing solutions were slightly higher than CMC/PEO solution. 
That’s why we did not observe the decreasing effect of higher conductivity in 
diameter for CD containing nanofibers.  
If we evaluate AFD results in detail; when we functionalized CMC 
nanofibers with 25%, 50%, 100% (w/w) HPβ-CD, we obtained functional CMC 
nanofibers which have 165±85, 160±40, 195±75 nm, respectively. As the 
amount of HPβ-CD increased, the viscosity of the solution also increased but the 
conductivity did not change much. That’s why increment in AFD is an expected 
result for HPβ-CD functionalized CMC nanofibers due to the increasing 
viscosity. Secondly, AFD of functional CMC nanofibers containing 25%, 50%, 
100% (w/w) Mβ-CD are 150±50, 185±80, 240±105 nm, respectively. The 
increase of AFD from 25% (w/w) to 50% Mβ-CD (w/w) and from 50% (w/w) to 
100% (w/w) Mβ-CD might be due to the little decrease in conductivity. Thirdly, 
25%, 50%, 100% (w/w) HPγ-CD including CMC nanofibers are 170±65, 
200±65, 295±100 nm, respectively. This increment is related with gradually 
decreasing conductivity.  
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Table 3. The characteristics of CMC, CMC/PEO and CD incorporated CMC 
solutions and the resulting electrospun ﬁbers. 
Solutions 
Conductivity 
(μS/cm) 
Viscosity (Pa.s) Diameter (nm) Fiber morphology 
CMC3 5.16 0.182 -  
CMC3/PEO1 4.34 0.258 100±35 bead-free nanofibers 
CMC3/PEO1/HPβ-CD25 6.33 0.355 165±85 bead-free nanofibers 
CMC3/PEO1/HPβ-CD50 5.64 0.617 160±60 bead-free nanofibers 
CMC3/PEO1/HPβ-CD100 5.96 0.683 195±75 bead-free nanofibers 
CMC3/PEO1/MβCD25 6.72 0.819 150±50 bead-free nanofibers 
CMC3/PEO1/MβCD50 6.26 0.325 185±80 bead-free nanofibers 
CMC3/PEO1/MβCD100 6.24 0.452 240±105 bead-free nanofibers 
CMC3/PEO1/HPγCD25 5.76 0.514 170±65 bead-free nanofibers 
CMC3/PEO1/HPγCD50 5.52 0.311 200±65 bead-free nanofibers 
CMC3/PEO1/HPγCD100 5.16 0.314 295±100 bead-free nanofibers 
 
2.6.3. Electrospinning of CD functionalized alginate nanofibers 
It is a known fact that electrospinning of pure alginate is not easy in 
aqueous solutions. This might be related with absence of chain entanglement in 
aqueous solutions due to the rigid and extended chain conformation of alginate 
[57]. Nevertheless, we firstly prepared pure alginate solutions which have total 
polymer concentrations ranging from 1.5% (w/v) to 4.5% (w/v) in aqueous 
solution. As a result, we only observed splashes on the collector, due to 
discontinuous jet formation. This result was consistent with the literature [57].  
Secondly, PEO was added into alginate solutions to improve the 
electrospinnability and uniformity of alginate-based nanofibers. PEO is known 
to form hydrogen bond interaction between its ether oxygen groups and 
hydroxyl groups of alginate. By this way it breaks the rigid structure of alginate 
[57]. For this purpose, alginate solution including alginate:PEO (1:1) was 
prepared in two different total concentrations (4%, 5% (w/v)). As seen from 
SEM images in Figure 16a, we were able to achieve bead-on-string structure 
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with 4% (w/v) polymer concentration. However, almost bead-free nanofibers 
were obtained from 5% (w/v) total polymer concentration (Figure 16b).  
4 μm 5 μma. b.
 
Figure 16. SEM images of electrospun alginate/PEO solutions at 1:1 ratio with 
different total polymer concentrations (a) 4% (w/v), (b) 5% (w/v) in aqueous 
solution.  
Then we tried to increase percentage of alginate and solutions having 3% 
(w/v) total concentration including 62% and 75% alginate were prepared (Figure 
17a, 17b). But we could not achieve to produce bead-free nanofibers from these 
solutions. Thus, Figure 17a exhibited bead-on-string structure; whereas only 
beads were observed in Figure 17b. On the other hand, 4% (w/v) total 
concentration including 62% and 75% alginate was also prepared (Figure 17c, 
17d). In Figure 17c, we observed beads and fibers at the same time; while in 
Figure 17d, beads were seen rather than bead-free nanofibers.  
Formation of beads may be the consequence of breaking up of spinning jet 
due to the high surface tension of the solution [1]. Therefore, we tried to reduce 
surface tension of the solution. So we added a nonionic surfactant called Triton 
X-100 into these solutions to improve the electrospinnability of the so-called 
solutions. In principle, surfactants reduce surface tension of polymer solution. 
Therefore, it is getting easier to overcome surface tension of polymer solution 
and indirectly electrospinning is facilitated [1]. But bead-on-string structure 
observed in Figure 17a did not change much (Figure 18a). On the other side, 
beaded structure in Figure 17b has changed to bead-on-string with the addition 
of surfactant (Figure 18b). Addition of Triton X-100 improved the spinnability 
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of both of the solutions prepared from 4% (w/v) total concentration (Figure 18c, 
18d). But the effect of Triton X-100 was best seen in Figure 18c.  
10 μma. 3μm
50 μm 10 μmd.c.
b.
 
Figure 17. SEM images of electrospun alginate/PEO solutions with 3% (w/v) 
total polymer concentrations and different ratios (a) 62:28 (b) 75:25; 4% (w/v)  
total polymer concentrations and different ratios (c) 62:28 (d) 75:25 in aqueous 
solution.  
5 μma. 3 μmb.
10 μmd.10 μmc.
 
Figure 18. SEM images of electrospun alginate/PEO solutions with 3% (w/v) 
total polymer concentrations and different ratios (a) 62:28 (b) 75:25; 4% (w/v) 
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total polymer concentrations and different ratios (c) 62:28 (d) 75:25 in aqueous 
solution including 1% (w/v) Triton X-100. 
Finally, we put in two types of modified CD in two different ratios (HPβ-
CD and HPγ-CD; 25% (w/w) and 50% (w/w)) into the solution that includes 4% 
(w/v) total polymer concentration with 62% alginate to functionalize alginate 
based nanofibers. These nanofibers could be find application for drug delivery 
and biomedical applications. The alginate based nanofibers including 25% 
(w/w) HPβ-CD was almost bead-free but it seems that CD facilitated 
spinnability of nanofibers and as a result much more nanofibers were collected 
compared to sample without CD (Figure 19a). When we increase the amount of 
HPβ-CD to 50% (w/w), we attained to produce bead-free nanofibers (Figure 
19b). In addition, amount of collected nanofibers has increased compared to 
nanofibers without CD due to the facilitating effect of CDs in nanofiber 
formation. Finally, the AFD of HPβ-CD functionalized alginate nanofibers 
comprising 25% and 50% HPβ-CD (w/w) are 100±30 nm and 140±35 nm, 
respectively. On the other hand, 25% (w/w) and 50% (w/w) HPγ-CD containing 
alginate based nanofibers were also produced (Figure 19c, 19d). As shown in 
SEM images of both of the samples, almost bead-free nanofibers were obtained. 
However, more nanofibers were collected on nanofibers including 50% (w/w) 
HPγ-CD as compared to 25% (w/w) HPγ-CD. In addition, the amount of 
nanofibers collected was not more than 50% (w/w) HPβ-CD containing 
nanofibers. Lastly, the AFD of HPγ-CD functionalized alginate nanofibers 
comprising 25% and 50% HPγ-CD (w/w) are 205±60 nm and 265±110 nm, 
respectively. As a conclusion, we thought that facilitating effect of both of the 
CDs (HPβ-CD and HPγ-CD) in spinnability of alginate based nanofibers might 
be related with viscosity of CD containing solutions. 
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Figure 19. SEM images of electrospun alginate/PEO (62:28) nanofibers 
incorporated (a) 25% (w/w)  HPβ-CD, (b) 50% (w/w)  HPβ-CD; (c) 25% (w/w)  
HPγ-CD, (d) 50% (w/w) HPγ-CD in aqueous solution including 1% (w/v) Triton 
X-100.  
2.7. Conclusion  
Polysaccharides are difficult polymers to be electrospun due to shear 
thinning property and lack of chain entanglement. However, we successfully 
achieved to electrospin nanofibers from three different polysaccharides (HPC, 
CMC, and alginate) with the addition of CDs. Here, CDs not only improve the 
electrospinnability but also functionalized the nanofibers which might be used in 
drug delivery, wound healing, tissue engineering applications. Since CD 
functionalized electrospun nanofibers have both high surface area to volume 
ratio and nanoporous structure of electrospun nanofibers; and inclusion complex 
formation ability of CDs with various molecules like unpleasant odors and 
organic wastes. 
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CHAPTER II. RELEASE of SULFISOXAZOLE from 
ELECTROSPUN HYDROXYPROPYL CELLULOSE 
NANOFIBERS INCORPORATING CYCLODEXTRIN 
INCLUSION COMPLEX 
 
3.1. General Information 
The drug delivery systems are used to reduce adverse side effects and 
improve bioavailability and therapeutic efficacy of drugs [77]. Polymeric drug 
delivery systems have various advantages like reduced toxicity, improved 
therapeutic effect, and convenience. On the other hand, they have disadvantages 
such as low efficiency and burst release at the initial stage compared to 
conventional dosage forms [78]. Polymeric nanofibers are used as drug carriers 
owing to their nanoporous structure and high surface area to volume ratio [79-
80]. The releasing behavior of a drug from a polymer matrix depends on many 
factors like loading capacity; drug/matrix interaction; the solubility of the drug 
in the polymer matrix and testing medium; the diffusion of the drug from the 
polymer matrix; the swelling ability and the solubility of the polymer matrix in 
the testing medium etc. [79-80].  
Electrospinning is one of the most extensively used techniques to produce 
polymeric nanofibers due to its simplicity and versatility [5]. Electrospun 
nanofibers have shown potentials to be used in biotechnology applications, 
particularly for the development of functional biomaterials for wound healing, 
drug delivery systems and scaffolds for tissue engineering [5]. Moreover, 
biomaterials for wound healing, drug delivery systems and scaffolds for tissue 
engineering are widely manufactured through the use of electrospinning [17-18]. 
Electrospinning of biopolymers functionalized with various molecule such as 
drug, antibacterial, protein, gene is of increasing interest [81-84]. 
Cyclodextrins (CDs) are cyclic oligosaccharides consisting of α-(1,4)-
linked glucopyranose units with a toroid-shaped molecular structure. It is a 
known fact that CDs form inclusion complexes (IC) with variety of molecules 
that have suitable characteristics in terms of polarity and dimension [39]. In 
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pharmaceutical industry, CDs are commonly used compounds. IC of CDs with 
hydrophobic drugs has many advantages like increasing solubility, enhancing 
stability; improving bioavailability, reducing dose and volatility of the 
hydrophobic drugs [40]. The hydroxyalkylated CDs like hydroxypropyl-beta-
cyclodextrin (HPβ-CD) is more suitable for the solubilization of drugs than the 
natural CDs, because of their greater aqueous solubility and lack of toxicity 
[85]. 
In this study, IC of sulfisoxazole (SFS) which is a hydrophobic drug 
(Figure 1a) with HPβ-CD (Figure 1b, 1c) (SFS/HPβ-CD-IC) was prepared at 1:1 
molar ratio. The schematic representation of SFS/HPβ-CD-IC was shown in 
Figure 1d. Then SFS/HPβ-CD-IC incorporating hydroxypropyl cellulose (HPC) 
nanofibers (SFS/HPβ-CD-IC-HPC-NFs) were produced through electrospinning 
method. SFS without HPβ-CD incorporated in HPC nanofibers (SFS-HPC-NFs) 
was also electrospun as control sample. The characterization of electrospun 
nanofibers were carried out by scanning electron microscopy (SEM), X-ray 
diffraction (XRD), differential scanning calorimetry (DSC) and 
thermogravimetric analysis (TGA). The release of SFS from SFS-HPC-NFs and 
SFS/HPβ-CD-IC-HPC-NFs were tested at 37°C in phosphate buffer solution 
(PBS) and the amount of released SFS was measured through the use of liquid 
chromatography-mass spectroscopy (LC-MS).  
3.2. Materials 
Hydroxypropyl cellulose (HPC, Mw ~ 300.000 g/mol, Scientific polymer 
products), polycaprolactone (PCL, Mn ~ 70.000-90.000 g/mol, Sigma aldrich), 
hydroxypropyl-beta-cyclodextrin (HPβ-CD, Wacker chemie AG, Germany), 
sulfisoxazole (SFS, Sigma aldrich, min. 99%), ethanol (Sigma aldrich, 99.8%), 
dichloromethane (DCM, Sigma aldrich, extra pure), acetonitrile chromasolv 
(Sigma aldrich), N,N-dimethylformamide (DMF, Riedel, pestanal), potassium 
phosphate monobasic (Riedel de haen), disodium hydrogen phosphate 12-
hydrate (Riedel de haen) and sodium chloride (Sigma-aldrich) were purchased 
and used as-received without any further purification.  
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Figure 20. Chemical structure of (a) SFS, (b) HPβ-CD; schematic 
representation of (c) HPβ-CD, and (d) SFS/HPβ-CD-IC.  
3.3. Production of electrospun nanofibers 
3% (w/v) HPC solution was prepared by dissolving HPC in ethanol and 
this solution was electrospun. Two types of drug delivery systems were prepared 
by incorporating SFS without HPβ-CD and SFS/HPβ-CD-IC into HPC 
nanofibers. The amount of SFS was determined as 1:1 molar ratio (SFS:HPβ-
CD), and for both of the samples same amount of SFS was used. In order to 
prepare SFS-HPC-NFs, SFS and 3% (w/v) HPC was dissolved in ethanol; and 
stirred overnight at room temperature. Afterwards this solution was electrospun 
into nanofibers. With regard to SFS/HPβ-CD-IC-HPC-NFs, SFS was dissolved 
in ethanol at room temperature. Then HPβ-CD were added into the solution; and 
stirred overnight at room temperature. Finally, 3% (w/v) HPC was added into 
the solution and the solution was stirred 6 hours more. Resultant solution was 
electrospun into nanofibers. HPC solution, SFS-HPC solution and SFS/HPβ-
CD-IC-HPC solution were loaded into a 3 ml plastic syringe with a needle inner 
diameter of 0.8 mm placed horizontally on the pump and were sent towards to 
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the collector at 1 ml/h rate.  16-18 kV was obtained from a high voltage power 
supply. Cylindrical metal covered with aluminum foil was used as a collector. 
Distance between needle tip and collector was 11 cm. Experiments were 
performed at 20-22°C, 21-22% humidity. 
On the other side, 10% (w/v) polycaprolactone (PCL) was dissolved in the 
binary solvent system containing 3:1 (DMF:DCM) and electrospun into 
nanofibers. PCL solution was loaded into a 3 ml plastic syringe with a needle 
inner diameter of 0.8 mm placed horizontally on the pump and was sent towards 
to the collector at 1 ml/h rate. Distance between needle tip and collector was 12 
cm and applied voltage was 15 kV. Experiments were performed at 20-21°C, 
21-22% humidity. 
3.4. Preparation of phosphate buffer 
PBS was chosen as a releasing medium for drug release tests. In order to 
prepare the buffer solution, 1.44 g of potassium phosphate monobasic, 10.74 g 
of disodium hydrogen phosphate 12-hydrate and 90 g of sodium chloride were 
dissolved in 1000 ml of distilled water. Finally, this solution was diluted with 
distilled water at the rate of 1:9. The pH of the prepared solution was determined 
around 7.  
3.5. Drug release assay 
PCL is a semi crystalline and hydrophobic polymer that is widely 
employed in electrospinning method. It is commonly used for biomedical 
applications as tissue engineering scaffold, drug delivery system and wound 
dressing material, due to its biocompatibility and biodegradability [29, 86-87]. 
For release experiments we prepared three layered composite nanofibers 
composed of nanofiber structures. As shown in Figure 2, there were SFS-HPC-
NFs or SFS/HPβ-CD-IC-HPC-NFs between two electrospun PCL nanofiber 
layers. 
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Figure 21. Schematic representation of release of SFS from SFS/HPβ-CD-IC-
HPC-NFs. 
Total immersion method was used to study the cumulative release proﬁles 
of drugs from SFS-HPC-NFs and SFS/HPβ-CD-IC-HPC-NFs containing 
composite nanofibers. Based on this technique, each of the SFS including 
composite nanoﬁbers was immersed in 30 ml of PBS releasing medium at 37°C. 
At a predetermined time intervals between 0 and 720 minutes, 0.5 ml of the test 
medium was withdrawn (i.e., sample solution) and an equal amount of the fresh 
medium was reﬁlled. The amount of the SFS in the sample solution was 
determined using LC-MS equipped with VWD UV detector against the 
predetermined calibration curve for SFS. The calibration samples were prepared 
in methanol. The data were carefully calculated to determine the cumulative 
amount of SFS released from the samples at each speciﬁed immersion period. 
The experiments were carried out in triplicate and the results were reported as 
the average±standard deviation. 
3.6. Measurements and characterization techniques 
The viscosity and conductivity of HPC solution, SFS-HPC solution and 
SFS/HPβ-CD-IC-HPC solution were determined by Brookfield Viscometer DV-
II+ Pro and Inolab pH/Cond 720-WTW, respectively.  
The morphologies and average fiber diameters (AFDs) of electrospun PCL 
nanofibers, electrospun HPC nanoﬁbers, SFS-HPC-NFs and SFS/HPβ-CD-IC-
HPC-NFs were examined by SEM (FEI – Quanta 200 FEG). Before taking SEM 
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images, samples were coated 6 nm Au/Pd. So as to calculate AFDs, around 100 
fibers were analyzed.  
XRD data for SFS, electrospun HPC nanoﬁbers, HPβ-CD, SFS-HPC-NFs 
and SFS/HPβ-CD-IC-HPC-NFs were recorded using a PANalytical X’Pert 
powder diffractometer applying Cu Kα radiation in a 2θ range 5°–30°. 
In order to investigate the thermal behavior of the drug in the electrospun 
nanoﬁbers; SFS, SFS-HPC-NFs and SFS/HPβ-CD-IC-HPC-NFs were assessed 
via DSC (Q 2000, TA Instruments, USA); and SFS, electrospun HPC 
nanoﬁbers, HPβ-CD, SFS-HPC-NFs and SFS/HPβ-CD-IC-HPC-NFs was tested 
through TGA (Q 500, TA Instruments, USA). For DSC measurement, the 
samples were prepared in an aluminum pan and were heated from 25°C to 
250°C at a rate of 20°C/min under nitrogen purge. TGA measurements were 
carried out under nitrogen atmosphere, the samples were heated up to 450°C at a 
constant heating rate of 20°C/min. 
The released amount of SFS from SFS-HPC-NFs and SFS/HPβ-CD-IC-
HPC-NFs was determined through LC-MS (Agilient, 1200 series) equipped with 
VWD UV detector. The column (Agilient C18) was 4.6 mmx50 mm that 
contains 1.8 µm packing and the detection was accomplished at 270 nm. Mobile 
phase, flow rate, injection volume, total run time were 100% acetonitrile, 0.7 
ml/min, 20 µl and 3 minutes, respectively. 
3.7. Results and discussion 
HPC is a hydrophilic polymer and synthesized by substitution some 
hydroxyl groups of cellulose with hydroxypropyl groups. It is generally used in 
food, pharmaceutical and tissue engineering applications due to its 
biodegradability and hydrophilicity [41-43]. In the literature, there are various 
polymer types that are used to produce nanofibers by electrospinning method for 
various applications, but studies on electrospinning of HPC is limited [44-45]. 
This is related with shear thinning property and lack of chain entanglement in 
polysaccharides. Due to the compact structures, polysaccharides are not able to 
form sufficient chain entanglements. So their electrospinning is quite difficult 
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[23,88]. Moreover, there is somehow limited study regarding biomedical 
applications of HPC nanofibers in the literature.  
The sulfonamide drugs have a basic chemical structure comprising a 
sulfanilamide group and five or six-member heterocyclic ring. SFS is a 
sulfonamide drug with an oxazole substituent. It is a weak acidic antibacterial 
and poorly soluble in water [89]. In the literature, there are studies regarding IC 
of SFS with β-CD and HPβ-CD in order to increase its solubility [89-90]. Here 
we incorporated SFS/HPβ-CD-IC in HPC nanofibers to benefit high surface area 
to volume ratio and highly porous structure of electrospun nanofibers; and high 
solubility of SFS/ HPβ-CD-IC at the same time.   
 Figure 22 showed the SEM images and AFDs of electrospun HPC 
nanofibers; SFS-HPC-NFs and SFS/HPβ-CD-IC-HPC-NFs. First of all, bead-
free HPC nanofibers were produced from 3% (w/v) polymer concentration. 
Secondly, incorporation of SFS into HPC nanofibers did not change the 
morphology of nanofibers. In addition, it was obviously seen that both of the 
electrospun HPC nanofibers  incorporating SFS have smooth surface and neither 
drug crystals nor aggregates was observed on the surfaces of these nanoﬁbers. It 
indicated that SFS was not on the surface of nanofibers. Similar results were 
reported for another type of drugs incorporated into electrospun nanofibers [79]. 
AFD of electrospun HPC nanofibers was 150±65 nm; whereas those of 
SFS-HPC-NFs and SFS/HPβ-CD-IC-HPC-NFs were 95±50 nm and 70±40 nm, 
respectively. This situation was explained by higher conductivity and lower 
viscosity of HPC solutions containing SFS compared to HPC solution as shown 
in Table 4. In addition, SFS/HPβ-CD-IC-HPC solution has higher conductivity 
and lower viscosity than SFS-HPC solution. That’s why AFD of SFS/HPβ-CD-
IC-HPC-NFs was lower than SFS-HPC-NFs. Taepaiboon et al. also showed the 
effect of conductivity and viscosity in the AFD of polyvinyl alcohol (PVA) 
nanofibers with the addition of four different drugs [33]. Moreover, the 
concentration of HPC polymer in the solution was reduced when polymer 
matrixes were loaded with SFS, so interaction of polymer with solvent 
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weakened and the evaporation of solvent became easier [91]. Therefore, the 
addition of SFS may decrease the concentration of polymer in the solution. In 
other words, the decrease in the viscosity of the solution led to the formation of 
thinner fibers.  
 
Figure 22. SEM images and AFD distributions of (a) electrospun HPC 
nanofibers, (b) SFS-HPC-NFs, (c) SFS/HPβ-CD-IC-HPC-NFs. 
Table 4. The characteristics of HPC solution, SFS-HPC solution and SFS/HPβ-
CD-IC- HPC solutions and the resulting electrospun ﬁbers. 
Solutions 
% HPCa 
(w/v) 
% HPβ-CDb 
(w/w) 
SFSb 
(w/w) 
Conductivity 
(μS/cm) 
Viscosity 
(cP) 
Diameter  
(nm) 
Fiber 
morphology 
HPC 3 - - 2.52 1355 150±65 
bead-free 
nanofibers 
SFS-HPC 3 - 9.11 4.13 975.2 95±50 
bead-free 
nanofiber 
SFS/HPβ-
CD-IC-HPC 
3 50 9.11 13.04 785.3 70±40 
bead-free 
nanofiber 
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a with respect to solvent. 
b with respect to polymer. 
As mentioned before, three layered composite nanofibers were prepared 
from electrospun PCL nanofibers and SFS-HPC-NFs or SFS/HPβ-CD-IC-HPC-
NFs for release experiments. SEM image of bead-free PCL nanofibers was 
shown in Figure 23 and AFD was calculated as 260±110 nm.  
5 μm
 
Figure 23. SEM image of electrospun PCL nanofibers. 
Figure 24 represents the XRD patterns of SFS, electrospun HPC 
nanofibers, HPβ-CD, SFS-HPC-NFs and SFS/HPβ-CD-IC-HPC-NFs. XRD 
diffractogram of SFS clearly confirmed the crystalline nature of SFS with sharp 
diffraction peaks. The diffractogram of the electrospun HPC nanofibers with 
broad diffraction peaks exhibited amorphous nature of the HPC polymer. This 
result was consistent with the literature which stated that characteristic 
diffraction peaks of cellulose are at around 2Ɵ=6-8° and 2Ɵ=15-20° [92].  XRD 
pattern of SFS-HPC-NFs was very similar to that of electrospun HPC 
nanofibers. In addition, the diffraction peaks of SFS were completely 
disappeared. This result supported the formation of an amorphous state of the 
drug in SFS-HPC-NFs. This situation was also observed in the study of Li et al. 
Thus, crystalline peaks of borneol were disappeared and amorphous state of 
borneol was observed inside the nanofibers [93]. As regards to HPβ-CD, there 
was no crystalline peak in its XRD pattern. Therefore, we may conclude that 
HPβ-CD has an amorphous structure. Celebioglu et al. has also shown the 
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amorphous structure of HPβ-CD nanofibers [94]. On the other hand, XRD graph 
of SFS/HPβ-CD-IC-HPC-NFs was similar to electrospun HPC nanofibers and 
the diffraction peaks of crystalline SFS were completely disappeared. As is 
known, when a molecule forms IC with CDs, its interaction with other 
molecules and the formation of crystalline aggregates is restricted [94]. 
Therefore, absence of crystalline peaks of SFS may indicate formation of IC 
between HPβ-CD and SFS. In the literature, the inclusion complexation between 
a guest molecule and CD was confirmed with disappearance of crystalline 
diffraction peaks of the guest molecule [95].  
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Figure 24. XRD patterns of (a) SFS, (b) electrospun HPC nanofibers, (c) HPβ-
CD, (d) SFS-HPC-NFs, (e) SFS/HPβ-CD-IC-HPC-NFs. 
Thermal properties of the SFS, SFS-HPC-NFs and SFS/HPβ-CD-IC-HPC-
NFs were investigated by means of DSC (Figure 25). The sharp endothermic 
peak observed at 198°C in the thermogram of SFS corresponded to the melting 
temperature of SFS [90]. However, this peak did not exist in DSC thermogram 
of SFS-HPC-NFs. This might be due to the inability of SFS to form crystalline 
aggregates inside the electrospun nanofibers. Therefore, the high surface area of 
electrospun nanofibers might cause solvent to evaporate rapidly; the mobility of 
SFS inside the fiber was restricted and there might be no time for SFS to 
recrystallize inside the matrix. So it was dispersed in amorphous state in the 
41 
 
electrospun HPC nanofibers. This similar result was observed about 
dexamethasone loaded PCL nanofibers in the study of Martins et al. in the 
literature [80]. As regards to DSC pattern of SFS/HPβ-CD-IC-HPC-NFs, the 
sharp endothermic peak of SFS at 198°C was not observed in these nanofibers 
as well. The disappearance of melting peak of SFS might show that SFS 
molecules were distributed inside the nanofibers without crystalline aggregates 
and it may also confirm the complexation of HPβ-CD with SFS [90].  
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Figure 25. DSC thermograms of (a) SFS, (b) SFS-HPC-NFs, (c) SFS/HPβ-CD-
IC-HPC-NFs. 
To determine thermal stability of electrospun HPC nanofibers; TGA 
measurements of SFS, electrospun HPC nanofibers , HPβ-CD, SFS-HPC-NFs 
and SFS/HPβ-CD-IC-HPC-NFs were carried out and curves were depicted in 
Figure 26. Thermal degradation of SFS started at about 190°C [90]. For as-spun 
HPC nanofibers, the weight loss beginning from 300°C represents the thermal 
degradation of HPC polymer. In the case of SFS-HPC-NFs, weight loss started 
at around 275°C which was due to the degradation of SFS and HPC. Therefore 
thermal stability of SFS has increased to higher temperature by encapsulation of 
free SFS in electrospun HPC nanofibers thanks to the interaction between SFS 
and HPC. Similar results were obtained for another drugs and polymer in the 
literature [33]. On the other hand, TGA curve of HPβ-CD exhibited two weight 
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loss stages: the initial weight loss below 100°C might be attributed to removal 
of water, while the major weight loss above 290°C corresponded to the main 
thermal degradation of HPβ-CD [90]. With respect to SFS/HPβ-CD-IC-HPC-
NFs; first of all, initial weight loss that is observed below 100°C might be due to 
the removal of water. Secondly, the main weight loss of SFS/HPβ-CD-IC-HPC-
NFs started approximately at 275°C, corresponding to the thermal degradation 
of SFS, HPC and HPβ-CD. So, the thermal stability of SFS did not improve by 
encapsulation of SFS/HPβ-CD-IC in electrospun HPC nanofibers. As a result 
we cannot draw conclusion whether IC exist or not between SFS and HPβ-CD 
from TGA results. 
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Figure 26. TGA thermograms of (a) SFS, (b) electrospun HPC nanofibers, (c) 
HPβ-CD, (d) SFS-HPC-NFs, (e) SFS/HPβ-CD-IC-HPC-NFs.  
Releasing of a drug from nanofibers is rapid in the first stage due to the 
high surface area to volume ratio and nanoporous structure enabling much more 
drug to diffuse into the releasing medium, and this is called burst effect [96]. 
Burst effect is primarily controlled by the solubility of the drug in the releasing 
medium, the drug diffusion coefficient and initial drug distributions within the 
polymer carrier [97, 98]. Rapid swelling or dissolution of polymer matrix will 
also give rise to burst release [80, 97, 98]. On the other hand, the sustained 
release from a polymer matrix is mainly controlled by not only the drug 
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diffusion through the matrix but also the dissolution of matrix [99-100]. So, as a 
consequence of initial surface erosion arising from the water penetrating into the 
nanofibers’ surface and high surface area, drug is released faster from the 
nanofibers at the initial stage as we mentioned before. Then water reaches inside 
the nanofibers; as a result swelled polymer and interconnected pores within the 
nanofibers released the remaining drug slowly, this situation is called sustained 
release [80]. 
The release profiles of SFS from composite nanofibers containing SFS-
HPC-NFs and SFS/HPβ-CD-IC-HPC-NFs were shown in Figure 27 as a 
function of submersion time. The experiments were carried out by total 
immersion method in PBS at the physiological temperature of 37°C for 720 
minutes. The release mechanism of SFS from both of the samples might include 
dissolution through polymer matrix, diffusion through water-filled pores in the 
matrix; and would be followed with complete drug liberation as a result of 
dissolution of matrix if only HPC nanofibers were used instead of composite 
nanofibers. Based on the results given in Figure 27, the shape of the release 
proﬁles for SFS-HPC-NFs and SFS/HPβ-CD-IC-HPC-NFs containing 
composite nanofibers was essentially similar and can be divided into three 
stages: In the initial stage (up to 180 minutes) near linear release kinetics was 
observed; thereafter release rate increased slightly until 600 minutes of 
immersion time for both of the nanofibers and finally followed by a steady 
release of up to 720 minutes in where the curve was a plateau. As a 
consequence, composite nanofibers including SFS-HPC-NFs and SFS/HPβ-CD-
IC-HPC-NFs exhibited rapid enough release at the first and second stage; and 
then sustained release for the third stage.  
In composite nanofibers containing SFS-HPC-NFs, about 67±30 ppm SFS 
was released within the first 180 minutes; and at the end of the 720 minutes, 
121±15 ppm SFS had been released from SFS-HPC-NFs. As is known, the 
solubility of drug in polymer solution is of great importance in the release 
behavior of drug. Although SFS is a hydrophobic drug, it is quite soluble in 
polymer solution; thus it was less likely to form a phase separation with HPC 
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polymer during the rapid elongation of the jet and evaporation of the solvent 
because of the large surface area of the as-spun nanofibers. As a result, when 
fiber completely dried during electrospinning, it was more likely to be inside the 
HPC nanofibers rather than the surface. This idea was supported by a study in 
the literature [78]. Secondly, SFS is hydrophobic molecule which means it is not 
soluble in the releasing medium. If it was hydrophilic, physical interaction 
between polymer and drug would be limited, it would be most likely to locate at 
the surface [98]. Thirdly, wetting and swelling of hydrophilic HPC nanofibers 
was slowed down; owing to higher thickness of the composite nanofibers.  In 
this case, the higher thickness of the matrix, the lower drug release rate was 
observed as in the study of Wang et al. [99]. Otherwise water could easily 
penetrate through the matrix, HPC nanofibers would wet, swell and dissolve 
rapidly and releasing rate of SFS would increase and moving of SFS through the 
pores would quickly lead to all SFS to release in the initial stage. So, we would 
observe only burst release; rather than the controlled release [99].   
In regard to composite nanofibers containing SFS/HPβ-CD-IC, the release 
increased up to 105±37 ppm in 180 minutes; and at the end of the 720 minutes, 
152±20 ppm SFS was released. In addition to the reasons for SFS-HPC-NFs 
containing composite nanofibers to exhibit sustained release, SFS/HPβ-CD-IC 
containing composite nanofibers has more reasons for showing sustained release 
behavior. Unlike the composite nanofibers containing SFS-HPC-NFs at the 
same load, nanofibers having SFS/HPβ-CD-IC released much more SFS in each 
time given on graph and the maximum amount of released SFS is almost 30 
ppm more in total than other sample. This situation might be related with the 
existence of HPβ-CD in the matrix. Thus, CDs have ability to enhance drug 
release from polymeric systems by increasing the concentration of diffusible 
species within the matrix [97]. When a hydrophobic drug makes complex with 
CDs; its solubility, dissolution rate and stability increases considerably. Because 
CD complex of a drug is usually much more hydrophilic than the free drug, 
nanofibers including IC wets easier, the crystalline structure disintegrates and 
the substance quickly dissolves. So CD complex increase the drug solubility, 
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[100]. This result complies with the literature. Panichpakdee et al. stated that 
solubility of asiaticoside was increased via inclusion complexation of 
asiaticoside with HPβ-CD [95]. Consequently, presence of CDs may lower the 
required dose of an active molecule by improving its solubility. SFS/HPβ-CD-
IC-HPC-NFs containing composite nanofibers were superior to SFS-HPC-NFs 
containing composite nanofibers. That’s why; it could be used as an efficient 
drug carrier system for hydrophobic drugs.  
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Figure 27. Cumulative release proﬁles of (a) SFS-HPC-NFs, (b) SFS/HPβ-CD-
IC-HPC-NFs. 
3.8. Conclusion 
SFS/HPβ-CD-IC-HPC-NFs were successfully produced via 
electrospinning. SEM, XRD, DSC and TGA were used to investigate the 
structural and thermal characterizations of nanofibers. SEM images exhibited 
that incorporation of SFS inside HPC nanofibers did not affect the morphology 
of electrospun HPC nanofibers. Higher drug release was achieved owing to the 
property of CDs to enhance the solubility of hydrophobic drugs. As a 
conclusion, composite nanofibers allowed us to obtain an excellent drug 
delivery system for controlled release of hydrophobic drugs. 
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CHAPTER III. RELEASE of α-TOCOPHEROL 
(VITAMIN E) from ELECTROSPUN 
POLYCAPROLACTONE NANOFIBERS INCORPORATING 
CYCLODEXTRIN INCLUSION COMPLEX 
 
4.1. General Information 
Polymeric drug delivery systems are superior to other drug delivery 
systems in terms of therapeutic effect, toxicity and convenience. However, they 
have also disadvantages like low efficiency in drug delivery and burst release of 
drugs [78]. On the other hand, due to the unique properties such as porous 
structure at nanoscale and high surface area to volume ratio, nanofibers are of 
outstanding importance in delivery of drugs [101].  
Electrospinning is a simple, versatile and cost-effective method to produce 
nanofibers. Electrospun nanofibers are used in many areas including tissue 
scaffolds, wound healing, drug delivery systems owing to their high surface to 
volume ratio and nanoporous structure [2].  
Cyclodextrins (CDs) are cyclic oligosaccharides and have truncated-cone 
shaped structure [39]. They form host-guest complexes with several kinds of 
compounds depending on the polarity and size of the compound according to 
cavity of CD [39]. Owing to the inclusion complex (IC) between CD and guest 
molecule, many improvements might be achieved such as  enhancing solubility, 
bioavailability and the chemical stability of poorly soluble drugs; increasing 
thermal stability of volatile substances [102].  
In this study, IC of α-Tocopherol (α-TC) (Vitamin E) (Figure 1a) with 
beta-cyclodextrin (β-CD) (Figure 1b, 1c) was prepared (α-TC/β-CD-IC) an then 
incorporated in poly caprolactone (PCL) including solution and electrospinning 
was performed. The schematic representation of α-TC/β-CD-IC was shown in 
Figure 1d. α-TC/β-CD-IC incorporated PCL nanofibers (α-TC/β-CD-IC-PCL-
NFs) were characterized via scanning electron microscopy (SEM), X-ray 
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diffraction (XRD), differential scanning calorimetry (DSC), thermogravimetric 
analysis (TGA). The release of α-TC into phosphate buffer saline (PBS) 
including methanol and tween 20 (PBMT) from untreated and UV-treated 
nanofibers was measured via high performance liquid chromatography (HPLC). 
Moreover, antioxidant activity was determined by UV-Vis NIR spectroscopy. α-
TC without β-CD incorporated in PCL nanofibers (α-TC-PCL-NFs) was used as 
a control sample for above-mentioned experiments.  
 
 
Figure 28. Chemical structure of (a) α-TC, (b) β-CD; schematic representation 
of (c) β-CD, and (d) α-TC/β-CD-IC.   
4.2. Materials 
Polycaprolactone (PCL, Mn ~ 70.000-90.000 g/mol, Sigma aldrich), 
beta-cyclodextrin (β-CD, Wacker chemie AG, Germany), α-Tocopherol (α-TC, 
Sigma aldrich), formic acid (FA, Sigma aldrich, extra pure 98-100%), acetic 
acid (AA, Sigma aldrich, extra pure 100%), methanol (Sigma Aldrich, extra 
pure), methanol chromasolv (Sigma aldrich), potassium phosphate monobasic 
(Riedel de haen), disodium hydrogen phosphate 12-hydrate (Riedel de haen), 
sodium chloride (Sigma aldrich), tween 20 (Sigma aldrich), 2,2-diphenyl-1-
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picrylhydrazyl (DPPH, Sigma aldrich) were used as purchased without any 
purification.  
4.3. Production of electrospun nanofibers 
PCL solution was prepared by dissolving PCL in FA/AA (1:3) and this 
solution was electrospun. Drug delivery systems were prepared by 
electrospinning of α-TC-PCL or α-TC/β-CD-IC-PCL solutions. The molar ratio 
of α-TC to β-CD was 2:1 in α-TC/β-CD-IC-PCL solution, and for both of the 
samples the same amount of α-TC was used. Firstly, α-TC-PCL solution was 
prepared. α-TC was dissolved in FA/AA (1:3) and PCL was added to this 
solution; then the solution was stirred at room temperature overnight. Vials were 
covered with aluminum foil during the stirring to protect α-TC from light-
induced degradation. As for α-TC/β-CD-IC-PCL solution, α-TC was dissolved 
in FA/AA (1:3) solution, then β-CD was added and this mixture was stirred 
overnight at room temperature. Vials were covered with aluminum foil during 
stirring period to protect α-TC from light-induced degradation. After stirring 
overnight, PCL was added; the solution stirred 6 hours more. PCL solution, α-
TC-PCL solution and α-TC/β-CD-IC-PCL solution loaded into 3 ml plastic 
syringe with a needle inner diameter of 0.8 mm were placed horizontally on the 
pump and sent towards to the collector at 0.5 ml/h rate. 15 kV was obtained 
from a high voltage power supply. Cylindrical metal covered with aluminum 
foil was used as a collector. Distance between needle tip and collector was 8 cm. 
Experiments were performed at 22°C-26°C, 17%-20% humidity. 
4.4. Preparation of phosphate buffer 
In order to prepare the PBS, 1.44 g potassium phosphate monobasic, 10.74 
g disodium hydrogen phosphate 12-hydrate and 90 g sodium chloride were 
dissolved in 1000 ml of distilled water. Then, this solution was diluted with 
distilled water at the rate of 1:9. In order to increase the solubility of α-TC in the 
releasing medium 10% methanol and 0.5% tween 20 were added into PBS and 
PBMT was obtained. pH of the releasing media was measured as about 7. 
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4.5. Drug release assay 
Total immersion method was used to study the cumulative release proﬁles 
of α-TC from α-TC-PCL-NFs and α-TC/β-CD-IC-PCL-NFs. Based on this 
technique, each of α-TC including (both in free form and IC) electrospun PCL 
nanoﬁber taken from the aluminum foil was immersed in 30 ml of PBMT at 
37°C, stirred at 50 rpm. At a speciﬁed immersion period between 0 and 1440 
minutes, 0.5 ml of the test medium was withdrawn and an equal amount of the 
fresh medium was reﬁlled. The amount of α-TC in the sample solution was 
determined using HPLC equipped with VWD UV detector against the 
predetermined calibration curve for α-TC. The calibration samples were 
prepared in PBMT. The data were carefully calculated to determine the 
cumulative amount of α-TC released from the samples at each speciﬁed 
immersion period. The experiments were carried out in triplicate and the results 
were reported as average values±standard deviation. 
4.6. Measurements and characterization techniques 
The viscosity and conductivity of PCL, α-TC-PCL and α-TC/β-CD-IC-
PCL solutions were determined by Brookfield Viscometer DV-II+ Pro and 
Inolab pH/Cond 720-WTW, respectively.  
The morphologies and average fiber diameters (AFDs) of electrospun PCL 
nanoﬁbers, α-TC-PCL-NFs and α-TC/β-CD-IC-PCL-NFs were examined by 
SEM (FEI – Quanta 200 FEG). SEM images of α -TC-PCL-NFs and α-TC/β-
CD-IC-PCL-NFs were also taken after HPLC measurement and UV treatment. 
Samples were coated 5 nm Au/Pd before taking SEM images. So as to calculate 
AFD, around 100 fibers were analyzed.  
XRD data for electrospun PCL nanoﬁbers, β-CD, α-TC-PCL-NFs and Α-
TC/β-CD-IC-PCL-NFs were recorded using a PANalytical X’Pert powder 
diﬀractometer applying Cu Kα radiation in a 2θ range 5°–30°. 
In order to investigate the thermal behavior of α-TC in electrospun 
nanoﬁbers; α-TC, electrospun PCL nanoﬁbers, β-CD, α-TC-PCL-NFs and α -
TC/β-CD-IC-PCL-NFs were assessed via DSC (Q 2000, TA Instruments, USA) 
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and TGA (Q 500, TA Instruments, USA). For DSC measurement, the samples 
were prepared in an aluminum pan and were heated from -90°C to 150°C at a 
rate of 20°C/min under nitrogen purge. TGA measurements were carried out 
under nitrogen atmosphere, the samples were heated up to 500°C at a constant 
heating rate of 20°C/min. 
Amount of released α-TC from α-TC-PCL-NFs and α -TC/β-CD-IC-PCL-
NFs were measured using HPLC (Agilient, 1200 series) equipped with VWD 
UV detector. The column was Agilient C18, 150 mm x 4.6 mm (5 µm pores) 
and the detection was accomplished at 292 nm. Mobile phase, flow rate, 
injection volume and total run time were 98:2 methanol:water, 1 ml/min, 10 µl 
and 12 minutes, respectively. 
α-TC-PCL-NFs and α-TC/β-CD-IC-PCL-NFs were tested for their 
photostability as well. Nanofibers were cut into square shaped samples and 
exposed to UV light a distance of 10 cm from the UV source (8W, UVLMS-38 
EL) at 365 nm for 45 minutes. Then each sample was submerged into 30 ml of 
PBMT at 37°C, stirred at 50 rpm for 1440 minutes; and 0.5 ml solution was 
withdrawn at certain time intervals and fresh PBMT was added instead. The 
released α-TC was measured by means of HPLC method as mentioned in release 
assay. These experiments were done triplicate and the results were reported as 
average values±standard deviation. 
Antioxidant tests for α-TC-PCL-NFs and α-TC/β-CD-IC-PCL-NFs were 
done via DPPH radical scavenging assay. PCL nanofibers were also used as a 
control sample for this assay. 10
-4
 M DPPH solution was prepared in methanol; 
meanwhile 2 mg nanofibers sample was dissolved in methanol. Then, 2.9 ml of 
DPPH solution was mixed with 0.1 ml of nanofibers solution. The mixture was 
remained in the dark for 30 minutes at room temperature. At the end of the 30 
minutes, the absorbance of the solution was measured with UV-Vis NIR 
Spectroscopy (Varian Cary 5000) at 517 nm during 5 minutes in every 1 minute.  
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4.7. Results and discussion  
PCL, a semi-crystalline polymer, is widely used in the field of 
biotechnology due to slow biodegradability, high biocompatibility, good drug 
permeability, mechanical properties and comparatively lower cost [29]. 
Electrospinning of PCL was studied by several groups in the literature. But 
generally organic solvents are used rather than acids [26]. Kanani et al. acquired 
to produce electrospun PCL nanofibers by using glacial acetic acid, 90% acetic 
acid, glacial formic acid, and formic acid / acetone [27].  
α-TC is the main component of Vitamin E and used in food and cosmetic 
industries. It is a natural antioxidant and poorly soluble compound [103].  In the 
literature, there are studies concerning IC preparation between α-TC with CDs 
[104-105] and loading of α-TC/CD-IC into polymeric films [106-108]. In these 
studies as prepared α-TC/β-CD-IC was acted as protective agent for α-TC or 
controlled release were achieved for α-TC. Here, we prepared α-TC/β-CD-IC- 
PCL-NFs were obtained via electrospinning.  
SEM was used to characterize the morphology of the electrospun PCL 
nanofibers.  SEM images and AFD distributions of electrospun PCL nanofibers, 
α-TC-PCL-NFs and α-TC/β-CD-IC-PCL-NFs were presented in Figure 29. As it 
is seen from Figure 29a, bead-free nanofibers of PCL were obtained from 15% 
(w/v) polymer concentration in FA/AA (1:3) solution. After the addition of α-
TC both free α-TC (Figure 29b) or α-TC/β-CD-IC (Figure 29c), the morphology 
of PCL nanofibers did not change.  
As shown in Table 5, the average diameters of electrospun PCL nanofibers 
was 285±105 nm; whereas α-TC-PCL-NFs was 345±270 nm and α-TC/β-CD-
IC-PCL-NFs was 495±350 nm. So, higher AFD of α-TC-PCL-NFs may be due 
to the lower conductivity compared to PCL solution; however, lower viscosity 
might suppress the increase in AFD. As regards to α-TC/β-CD-IC-PCL-NFs, its 
AFD was also higher than PCL nanofibers. This is related with lower 
conductivity of α-TC/β-CD-IC-PCL solution than PCL solution.  
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Figure 29. SEM images and AFD distributions of (a) electrospun PCL 
nanofibers, (b) α-TC-PCL-NFs, (c) α-TC/β-CD-IC-PCL-NFs. 
Table 5. The characteristics of PCL, α-TC-PCL and α-TC/βCD-IC- PCL 
solutions and the resulting electrospun ﬁbers. 
Solutions 
% PCLa 
(w/v) 
% βCDb (w/w) 
α-TC b 
(w/w) 
Conductivity 
(μS/cm) 
Viscosity 
(cP) 
Diameter  
(nm) 
Fiber 
morphology 
PCL 15 - - 4.7 1795 285±105 
bead-free 
nanofibers 
α-TC-PCL 15 - 10 4.0 1156 345±270 
bead-free 
nanofiber 
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α-TC /βCD-
IC-PCL 
15 13.33 10 4.3 1631 495±350 
bead-free 
nanofiber 
a with respect to solvent. 
b with respect to polymer 
XRD patterns of electrospun PCL nanofibers, β-CD, α-TC-PCL-NFs and 
α-TC/β-CD-IC-PCL-NFs were displayed in Figure 30. α-TC is a liquid 
compound at room temperature, so it has no diffraction peak. Electrospun PCL 
nanofibers exhibited characteristic peaks of semi-crystalline PCL at 2θ=21.7◦ 
and 24.0◦. α-TC-PCL-NFs showed very similar XRD pattern with PCL 
nanofibers. Similarly, α-TC/β-CD-IC-PCL-NFs showed only characteristic 
peaks of PCL. β-CD exhibits channel type packing when it forms IC with a 
guest molecule and has its own characteristic diffraction peaks [109]. But 
characteristic channel type packing peaks of β-CD (2θ=12◦, 18◦) was not 
observed in α-TC/β-CD-IC-PCL-NFs. Therefore, XRD results did not draw a 
clear conclusion that α-TC molecules formed IC with β-CD or not. 
a.
b.
c.
d.
5 10 15 20 25 30
in
te
n
s
‏it
y
‏(
a
.u
.)
2 theta
 
Figure 30. XRD patterns of (a) electrospun PCL nanofibers, (b) β-CD, (c) α-
TC-PCL-NFs, (d) α-TC/β-CD-IC-PCL-NFs. 
Differential scanning calorimetry was performed for α-TC, electrospun 
PCL nanofibers, β-CD, α-TC-PCL-NFs and α-TC/β-CD-IC-PCL-NFs (Figure 
31). α-TC had a glass transition at around -40°C which was confirmed by 
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literature as well [105]. PCL is a semi-crystalline polymer with a sharp peak at 
58°C that corresponds to the melting temperature of polymer. α-TC-PCL-NFs 
had very similar thermal degradation profile to PCL nanofibers. Thus, it shows 
sharp endothermic peak at around 57°C, whereas it does not exhibit glass 
transition of α-TC. Thereby, we might deduce that α-TC molecules were well 
dispersed in PCL nanofibers. 
The disappearance of thermal transitions of guest molecule clearly 
indicates that guest molecule is in the cavity of CD; therefore the formation of 
IC between CD and guest molecule is proved as well [105]. So, disappearance 
the peaks of both α-TC and β-CD for α-TC/β-CD-IC-PCL-NFs showed that 
there is an interaction between α-TC and β-CD. Moreover, we might conclude 
that IC formation was successfully achieved in α-TC/β-CD-IC-PCL-NFs.  
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Figure 31. DSC thermogram of (a) α-TC, (b) electrospun PCL nanofibers (c) β-
CD, (d) α-TC-PCL-NFs, (e) α-TC/β-CD-IC-PCL-NFs. 
TGA is used to determine thermal stability of nanofibers. Figure 32 
displayed the TGA measurements for α-TC, electrospun PCL nanofibers, β-CD, 
α-TC-PCL-NFs and α-TC/β-CD-IC-PCL-NFs. The thermal degradation of α-TC 
began at around 230°C and this result was correlated with the literature [110]. 
The onset temperature for degradation of PCL is 360°C and its degradation 
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finished at about 450°C similar with literature [111]. α-TC-PCL-NFs   exhibited 
two weight losses: In the first weight loss that might corresponds to the 
degradation of α-TC, the degradation started at around 230°C. So, the onset of 
degradation temperature of α-TC did not change. Whereas in the second weight 
loss the degradation began about 360°C and it may attributed to the degradation 
of PCL. With regard to α-TC/β-CD-IC-PCL-NFs, there existed two degradation 
points in the curve. The first one ascribed to the decomposition of α-TC and 
started at 230°C, thus the thermal stability of α-TC was not improved. The 
second weight loss of α-TC/β-CD-IC-PCL-NFs beginning at around 350°C and 
finished at around 440°C may belong to the decomposition of β-CD and PCL. 
Typically, β-CD represents water loss below 100°C and weight loss above 
275°C corresponded to the main thermal degradation of β-CD [112]. Finally, as 
there was no increase in the thermal stability of α-TC, we cannot conclude that 
there was an IC between α-TC and β-CD or not [105].  
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Figure 32. TGA thermograms of (a) α-TC, (b) electrospun PCL nanofibers (c) 
β-CD, (d) α-TC-PCL-NFs, (e) α-TC/β-CD-IC-PCL-NFs. 
The release experiments were done in PBMT according to total immersion 
method at the physiological temperature of 37°C and 50 rpm for 1440 minutes. 
Percent of released α-TC in PBMT from α-TC-PCL-NFs and α-TC/β-CD-IC-
PCL-NFs were presented in Figure 33 as versus of time. SEM images of 
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nanofibers were also taken after HPLC measurement; and as seen from Figure 
34, the samples kept their fiber structure after immersion into PBTM.  
As shown, zero-order release kinetic was observed for both α-TC-PCL-
NFs and α-TC/β-CD-IC-PCL-NFs. We can analyze the release of α-TC from 
both of the nanofibers basically in 3 stages. In the first stage that is up to 60 
minutes, α-TC exhibited relatively quick release. Afterwards release of α-TC 
continued with lower rate compared to first stage until 240 minutes of 
immersion time. During this stage, water molecules penetrated inside PCL 
nanofibers deeply, PCL swelled and bulk erosion occurred. Lastly, the drug was 
released at a constant rate from interconnected pores in the third stage [80, 106].  
α-TC is hydrophobic molecule, it is not soluble in PBS; however we added 
methanol and tween 20 to buffer solution in order to help dissolution of α-TC 
and detection of α-TC in HPLC. Additionally, α-TC was not soluble in polymer 
solution; therefore, its interaction with polymer was weak and partition of α-TC 
from polymer matrix occurred rapidly [113]. As nanofibers have unique 
properties like high surface area to volume ratio and nanoporous structure; 
diffusion rate of a molecule from nanofibers was rapid in the first stage [114]. α-
TC-PCL-NFs released 11±3 ppm α-TC; whereas α-TC/β-CD-IC-PCL-NFs 
released 9±6 ppm α-TC within the first 60 minutes. The initial release of α-TC 
was slower in α-TC/β-CD-IC-PCL-NFs compared with α-TC-PCL-NFs; because 
α-TC molecules were in the cavity. The difference is basically related with 
lower diffusion coefficient of α-TC/β-CD-IC-PCL-NFs and higher molecular 
weight of α-TC/β-CD-IC. This became clear after 30 minutes of immersion. It is 
known that presence of another compound in a solution reduces the diffusion 
rate [108]. In our case, IC between α-TC and β-CD might reduce the diffusion 
rate of α-TC. Finally, α-TC-PCL-NFs released more α-TC than α-TC/β-CD-IC-
PCL-NFs in total. So; at the end of 1440 minutes, 21±2 ppm α-TC was released 
from α-TC-PCL-NFs; while 17±3 ppm α-TC was released from α-TC/β-CD-IC-
PCL-NFs. Consequently; the release rate gradually decreased and sustained 
release of α-TC was achieved with α-TC/β-CD-IC-PCL-NFs [106,108]. In fact, 
this is very applicable for most of the drugs.  
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Figure 33. Cumulative release proﬁles of (a) α-TC-PCL-NFs, (b) α-TC/β-CD-
IC-PCL-NFs. 
5 μma. 10 μmb.
 
Figure 34. SEM images of (a) α-TC-PCL-NFs, (b) α-TC/β-CD-IC-PCL-NFs 
after HPLC. 
It is known fact that α-TC degrades when exposed to UV light [103]. 
That’s why; the percent of released α-TC from α-TC-PCL-NFs and α-TC/β-CD-
IC-PCL-NFs samples after UV treatment for 45 minutes were investigated and 
shown in Figure 35. We calculated percent of released α-TC at the end of 1440 
minutes, with the assumption of that the amount of α-TC released from 
untreated nanofibers at the end of 1440 minutes as 100% for each sample. 
Therefore, α-TC-PCL-NFs released 75% of α-TC; whereas, α-TC/β-CD-IC-
PCL-NFs released 84% of α-TC after UV treatment for 45 minutes. So, the 
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protection of α-TC from UV light was more effective in α-TC/β-CD-IC-PCL-
NFs. This situation is related with inclusion complexation between α-TC and β-
CD [115]. The SEM images were taken after UV treatment as well (Figure 36). 
However, nanofibers kept their fiber structure after UV treatment for 45 
minutes. 
 
Figure 35. Percent of released α-TC from α-TC-PCL-NFs and α-TC/β-CD-IC-
PCL-NFs after UV treatment for 45 minutes. 
10 μma. 10 μmb.
 
Figure 36. SEM images of (a) α-TC-PCL-NFs, (b) α-TC/β-CD-IC-PCL-NFs 
after UV treatment for 45 minutes. 
The antioxidant activity of α-TC within α-TC/β-CD-IC-PCL-NFs was 
determined via DPPH radical scavenging assay. Electrospun PCL nanofibers 
and α-TC-PCL-NFs were used as control samples. The results were obtained 
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after 30 minutes of reaction in the dark between α-TC and DPPH and the graph 
was plotted absorbance (%) versus time in Figure 37. When α-TC encounter 
with an oxidant compound it loses its phenolic hydrogen and α-tocopheroxyl 
radical is formed. The abovementioned radical is highly stable and bind another 
radical by forming non-radical products or α-TC [116]. DPPH with a violet 
color is a stable free radical which can readily be scavenged by an antioxidant 
substance and that’s why it is widely used compound to test the antioxidant 
activity of various molecules. The antioxidant activity of an antioxidant 
substance can be measured spectrophotometrically at 517 nm by the loss of 
absorbance as the pale yellow non-radical form (DPPH-H) is produced. In 
scavenging mechanism, antioxidant molecule acting as a donor of a hydrogen 
atom transform a DPPH radical into its reduced form DPPH; thus free radical 
character of DPPH is neutralized [117].  
Initially, the violet color of solution in the beginning of the experiment 
turned to pale yellow at the end of 35 minutes. At the initial stage of UV 
measurement absorbance at 517 nm reduced, and then reached a plateau in 5 
minutes, so there existed no more DPPH to deactivate in the solution [118].  
From the reduction of the DPPH solution’s absorbance at 517 nm, the 
antioxidant activity was calculated with the help of following formula: 
 
where AB is the absorption of the blank and AS is the absorption of the sample 
[118]. Therefore, the antioxidant activity of electrospun PCL nanofibers, α-TC-
PCL-NFs and α-TC/β-CD-IC-PCL-NFs were calculated as 19%, 43% and 63%, 
respectively. Firstly, high surface area to volume ratio of electrospun nanofibers 
might lead to absorption certain amount of DPPH and as a result electrospun 
PCL nanofibers exhibited 19% antioxidant activity. This situation was reported 
in the literature [118]. Secondly, antioxidant activity of α-TC/β-CD-IC-PCL-
NFs was almost 20% more than α-TC-PCL-NFs. In addition, it is a known fact 
that CDs have no ability to degrade DPPH from the literature [119]. Owing to 
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the inclusion complexation between α-TC and β-CD, the solubility of α-TC 
might have increased; so enhanced solubility of α-TC may be the main reason of 
higher antioxidant activity of α-TC/β-CD-IC-PCL-NFs. This result was 
consistent with literature as well [120-121]. Finally, we can conclude that after 
electrospinning α-TC including (both in free form and IC) PCL nanofibers still 
maintained their antioxidant property in spite of high electrical potential applied 
during electrospinning onto α-TC (both in free form and IC) containing PCL 
solutions [114].   
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Figure 37. Antioxidant activity of (a) electrospun PCL nanofibers, (b) α-TC-
PCL-NFs, (c) α-TC/β-CD-IC-PCL-NFs. 
4.8. Conclusion 
α-TC/β-CD-IC was prepared, incorporated into PCL and nanofibers were 
produced via electrospinning technique. The characterization of nanofibers was 
done by SEM, XRD, DSC, and TGA. As observed in SEM images incorporating 
α-TC into nanofibers, immersing these nanofibers in PBTM and exposing them 
to UV light did not result in any deformation in the morphology of nanofibers. 
α-TC/β-CD-IC-PCL-NFs showed controlled release and better photostability 
than α-TC-PCL-NFs. Moreover, α-TC/β-CD-IC-PCL-NFs displayed much 
61 
 
higher antioxidant activity as compared to α-TC-PCL-NFs, due to the higher 
solubility of α-TC. 
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CHAPTER IV. RELEASE of ALLYL ISOTHIOCYANATE 
from ELECTROSPUN POLYVINYL ALCOHOL 
NANOFIBERS INCORPORATING CYCLODEXTRIN 
INCLUSION COMPLEX 
 
5.1. General Information  
The drug delivery systems are designed to reduce side effects, and 
improve bioavailability and therapeutic efficacy of drugs. Polymeric drug 
delivery systems have higher therapeutic effect, convenience, and lower toxicity 
than conventional drug delivery systems. However, burst release at the initial 
stage and low efficiency in drug delivery are the main problems of polymeric 
drug delivery systems [78].  Electrospinning is a widely used method to produce 
nanofibers with unique properties like high surface area to volume ratio and 
nanoporous structure [5]. These unique properties enable them to be used in 
wound dressing, tissue scaffold and drug delivery applications [101].   
Cyclodextrins (CDs) are cyclic oligosaccharides and they have a 
hydrophobic cavity. Owing to this cavity, CDs are able to form host-guest 
complexes with molecules in appropriate polarity and dimension. Inclusion 
complex (IC) of CDs with a guest molecule has advantages like higher solubility 
of hydrophobic guests, higher thermal stability and bioavailability, control of 
volatility, masking off unpleasant odors, and controlled release of drugs and 
flavors [38].  
In this study, allyl isothiocyanate (AITC) (Figure 38a) encapsulated 
electrospun polyvinyl alcohol (PVA) nanofibers were generated. IC of AITC 
and beta-cyclodextrin (β-CD) (Figure 38b, 38c) (AITC/β-CD-IC) was prepared 
in aqueous solution and then incorporated in PVA solution; lastly AITC/β-CD-
IC including PVA nanofibers (AITC/β-CD-IC-PVA-NFs) was produced via 
electrospinning. The schematic representation of AITC/β-CD-IC was shown in 
Figure 38d. The resulting AITC/β-CD-IC-PVA-NFs were characterized by 
scanning electron microscope (SEM), X-ray diffraction (XRD), 
thermogravimetric analysis (TGA), and gas chromatography-mass spectrometry 
63 
 
(GC-MS). The antibacterial activity of AITC/β-CD-IC-PVA-NFs was tested 
against Escherichia coli (E.coli) and Staphylococcus aureus (S.aureus) 
according to colony counting method. The sustained released behavior and quite 
high antibacterial activity of AITC/β-CD-IC-PVA-NFs enable these nanofibers 
to be used in wound healing applications. 
 
Figure 38. Chemical structure of (a) AITC, (b) β-CD; schematic representation 
of (c) β-CD, and (d) AITC/ β-CD-IC. 
5.2. Materials 
Polyvinyl alcohol (PVA, Mw ~ 85.000-146.000 g/mol, Sigma aldrich, 87-
89% hydrolyzed), allyl isothiocyanate (AITC, Sigma aldrich, 95%), beta-
cyclodextrin (β-CD, Wacker chemie AG, Germany) were purchased and used 
as-received without any further purification. Distilled water was supplied from 
Millipore Milli-Q Ultrapure Water System. 
5.3. Production of electrospun nanofibers 
PVA solution was prepared by dissolving PVA (7.5% (w/v)) in aqueous 
solution and this solution was electrospun. Drug delivery systems were prepared 
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by electrospinning of AITC without β-CD including PVA (AITC-PVA) solution 
or AITC/β-CD-IC including PVA (AITC/β-CD-IC-PVA) solution. AITC/β-CD-
IC was prepared at 2:1 molar ratio (AITC:β-CD). The same amount of AITC 
was used for both of the samples. Initially, AITC-PVA solution was prepared. 
AITC was dissolved in aqueous solution and PVA (7.5% (w/v)) was put in this 
solution; then the solution was stirred at room temperature overnight. With 
regard to, AITC was dispersed in water for 0.5 hour and clear solution was 
obtained. Then β-CD was added and resulting solution was stirred overnight at 
room temperature and white, turbid solution was obtained. This turbidity might 
be due to aggregation of AITC/β-CD-IC. Then, PVA (7.5% (w/v)) was put in 
and stirred 6 hours more at room temperature. Lastly, PVA solution, AITC-PVA 
solution and AITC/β-CD-IC-PVA solution were loaded into a 3 ml plastic 
syringe with a needle inner diameter of 0.8 mm placed horizontally on the pump 
and was sent towards to the collector at 1 ml/h rate.  15 kV was obtained from a 
high voltage power supply. Cylindrical metal covered with aluminum foil was 
used as a collector. Distance between needle tip and collector was 10 cm. 
Experiments were performed at 24-25°C, 17-20% humidity. 
 
5.4. Measurements and characterization techniques  
The morphologies and average fiber diameters (AFDs) of PVA nanofibers 
and AITC/β-CD-IC-PVA-NFs were examined by SEM (FEI – Quanta 200 
FEG). Before taking SEM images, samples were coated 5 nm Au/Pd. In order to 
calculate AFDs, around 100 fibers were analyzed.  
XRD data for PVA nanofibers, β-CD and AITC/β-CD-IC-PVA-NFs were 
recorded using a PANalytical X’Pert powder diﬀractometer applying Cu Kα 
radiation in a 2θ range 5°–30°. 
In order to investigate the thermal stability of AITC in the electrospun 
nanoﬁbers; AITC/β-CD-IC-PVA-NFs were assessed via TGA (Q 500, TA 
Instruments, USA). AITC, electrospun PVA nanofibers and β-CD were also 
tested for comparison. The measurements were carried out under nitrogen 
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atmosphere, the samples were heated up to 500°C at a constant heating rate of 
20°C/min. 
The amount of released AITC from AITC without β-CD including PVA 
nanofibers (AITC-PVA-NFs) and AITC/β-CD-IC-PVA-NFs were determined 
by headspace GC-MS of Agilent Technologies 7890A gas chromatograph 
coupled to an Agilent Technologies 5975C inert MSD with a triple-axis detector 
for 300 minutes. AITC-PVA-NFs were used as control sample. The used 
capillary column was HP-5MS (Hewlett-Packard, Avondale, PA) (30ml X 
0.25mm i.d., 0.25μm film thickness). 20 mg of AITC-PVA-NFs and AITC/β-
CD-IC-PVA-NFs were placed in 20 mL headspace glass vials. The vials were 
agitated at 500 rpm at 37°C of incubation temperature. Helium was used as 
carrier gas was at a flow rate of 1.2 mL/min. Five hundred microliters of vapor 
was injected to the GC-MS by using a headspace injector (MSH 02-00B, 
volume = 2.5 mL, scale = 60 mm). The syringe temperature was 50°C. Oven 
temperature was held at 50°C for 1 min and increased to 200°C at the rate of 
20°C/min and held at this temperature for 3 min. Thermal desorption was 
conducted in the split mode (20:1). GC-MS analyses were carried out in the 
complete selected ion monitoring mode (SIM). Flavor 2 and NIST 0.5 libraries 
were used to decide AITC peak. The retention time of AITC was 11.5 minutes. 
For calibration samples were put in vials and analyzed with same parameters as 
nanofibers samples. Two samples were tested and results were given as average. 
The antibacterial activity of AITC/β-CD-IC-PVA-NFs was tested against 
both gram-negative bacterium and gram-positive bacterium which are E.coli and 
S. aureus, respectively. This test was assessed by colony counting method. 
400μL of the overnight grown E. coli and S. aureus were inoculated into 40 mL 
of Luria-Bertani (LB) broth (in 100 mL-flask) and AITC/β-CD-IC-PVA-NFs 
was sterilized by UV irradiation and put into the flasks. The mediums with 
bacteria and nanofibers were incubated at 37⁰C and 125 rpm for 24 hours. 
Controls were E. coli and S. aureus grown at 37⁰C and 125 rpm for 24 hours 
without fibers. Samples from each flask and controls were serially diluted, 
100μL of each was spread onto LB agar and colonies were counted. All samples 
66 
 
and controls were performed in triplicate and reported as average. The colony 
forming units (cfu) of bacteria with fibers were compared to controls. 
5.5. Results and discussion  
PVA is a polymer that is widely used in biomedical applications owing to its 
biocompatibility and biodegradability. Electrospun PVA nanofibers found 
application in drug delivery, tissue engineering and wound healing [33, 122-
123]. AITC is an antimicrobial compound found in horseradish, mustard, and 
wasabia [124-125]. It could be used in wound dressing applications [126-127] as 
well as food packaging [128-129]. IC of AITC with CDs was investigated as 
well [125, 130]. In a study, Ohta et al. prepared IC of AITC with alpha-
cyclodextrin (α-CD) and beta-cyclodextrin (β-CD); and deduced that 
decomposition of AITC was reduced by inclusion complexation [130]. In 
another study, Li et al. investigated controlled release property of AITC/α-CD-
IC and AITC/β-CD-IC. They concluded that the release of AITC increased as 
relative humidity increases, and the release rate of AITC was slower in AITC/α-
CD-IC compared to AITC/β-CD-IC [125]. Here, we produced AITC/β-CD-IC-
PVA-NFs via electrospinning. Therefore, we combined high surface area and 
nanoporous structure of electrospun nanofibers with high solubility of AITC/β-
CD-IC. 
Figure 39 showed the SEM images and AFD distributions of electrospun 
PVA nanofibers and AITC/β-CD-IC-PVA-NFs. Initially, we produced bead-free 
PVA nanofibers (7.5% (w/v)) in aqueous solution through electrospinning and 
AFD was calculated as 290±65 nm. Then we incorporated AITC/β-CD-IC into 
PVA solution and electrospinning was performed. As seen in SEM images, 
incorporation of AITC/β-CD-IC into PVA nanofibers did not change the 
morphology of nanofibers. On the other hand, the AFD of AITC/β-CD-IC-PVA-
NFs was 235±90 nm. The slightly thinner nanofiber formation was likely due to 
the lower viscosity and/or higher conductivity of AITC/β-CD-IC-PVA solution 
than PVA solution [1]. 
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Figure 39. SEM images and AFD distributions of (a) electrospun PVA nanofibers, (b) 
AITC/β-CD-IC-PVA-NFs.  
The XRD patterns of electrospun PVA nanofibers, β-CD and AITC/β-CD-
IC-PVA-NFs were depicted in Figure 40. Since AITC is liquid at room 
temperature, it has no crystalline diffractions. PVA is an amorphous polymer 
with a broad diffraction at around 2θ~19.6. Our data were supported by the 
literature [131]. On the other hand, once β-CD forms IC with a guest molecule; 
the cage type packing turns into channel type packing. The channel type packing 
of β-CD has two characteristic peaks at 2θ~12◦ and 18◦. The observation of 
characteristic peaks of channel type packing on XRD pattern indicates IC 
formation between CD and guest molecule [132]. Therefore; as we observed 
peak at 2θ~12◦, we concluded that there might be IC formation between AITC 
and β-CD in AITC/β-CD-IC-PVA-NFs. In addition; the difference from cage 
type packing of β-CD curve supported IC formation. 
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Figure 40. XRD patterns of (a) electrospun PVA nanofibers, (b) β-CD, (c) 
AITC/β-CD-IC-PVA-NFs. 
TGA was performed to investigate thermal stability of AITC/β-CD-IC-
PVA-NFs (Figure 41). AITC, electrospun PVA nanofibers, β-CD were also 
tested by TGA for comparison. AITC is known to be a volatile compound, that’s 
why its decomposition was below 100°C. This result was consistent with the 
literature [128]. Electrospun PVA nanofibers exhibited weight loss starting 
~250°C that corresponds to the main thermal degradation of PVA [133]. On 
other side, thermal degradation of β-CD occurs in two steps. One of them was 
water loss which continues up to 100°C; whereas the second was main thermal 
degradation of β-CD which was above ~275°C [128]. With respect to TGA 
thermogram of AITC/β-CD-IC-PVA-NFs, the first weight loss below 100°C 
might be attributed to the water loss; the second weight loss which was between 
~200°C and ~375°C was likely due to the AITC, β-CD and PVA loss. As a 
result, incorporation of AITC/β-CD-IC in PVA nanofibers has greatly improved 
the thermal stability of AITC. Therefore, it was concluded AITC might form IC 
with β-CD. This was also observed in the literature [128]. 
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Figure 41. TGA thermograms of (a) AITC, (b) electrospun PVA nanofiber, (c) 
βCD, (d) AITC/βCD inclusion complex incorporated electrospun PVA 
nanofibers.  
The release behavior of AITC from AITC/β-CD-IC-PVA-NFs was 
evaluated by GC-MS for 300 minutes (Figure 42). 20 mg of AITC/β-CD-IC-
PVA-NFs were placed in headspace glass vials and stirred at 37°C during the 
experiment. According to the calibration curve the results were converted to 
concentration versus time. AITC-PVA-NFs were also tested as a control sample. 
The release of AITC was relatively quick in the initial stage, then release rate of 
AITC reduced and finally constant release was observed [125]. Therefore, we 
successfully achieved to produce AITC/β-CD-IC-PVA-NFs with a sustained 
release behavior. On the other hand, the release values of AITC-PVA-NFs were 
only 1.6% of AITC/β-CD-IC-PVA-NFs. However, at the end of 300 minutes 
AITC/β-CD-IC-PVA-NFs released almost 67% of AITC that we theoretically 
put in the solution. This result showed that β-CD prevented AITC to evaporate 
during preparation of solution or electrospinning process. This result was in 
consistence with the literature [129]. 
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Figure 42. Cumulative release of (a) AITC-PVA-NFs, (b) AITC/β-CD-IC-
PVA-NFs.  
Antibacterial activity of AITC/β-CD-IC-PVA-NFs was tested by colony 
counting method against E.coli and S. aureus for 24 hours. Figure 43 presented 
exemplary images of bacteria, bacteria colonies treated by AITC/β-CD-IC-PVA-
NFs and the growth inhibition rate (%) of AITC/β-CD-IC-PVA-NFs for both 
E.coli and S. aureus. It was calculated by assuming plates without nanofibers as 
100%. AITC/β-CD-IC-PVA-NFs exhibited 97.62% antibacterial activity against 
E.coli; whereas antibacterial activity against S.aureus was 99.19%. The 
difference in the antibacterial activity against E.coli and S.aureus is likely 
related with difference between cell wall composition of two bacteria which are 
gram negative and gram positive, respectively. Thus gram negative bacteria 
have a semi-permeable barrier that decelerates passing of macromolecules and 
hydrophobic compounds [133]. Moreover, electrospinning in which we applied 
high voltage has no negative effect on the antibacterial property of AITC/β-CD-
IC-PVA-NFs. 
71 
 
 
Figure 43. Exemplary images of (a) control sample - colonies of E.coli and (b) 
S.aureus; c) E.coli colonies and (d) S.aureus colonies treated by AITC/β-CD-IC-
PVA-NFs; (e) antibacterial activity of AITC/β-CD-IC-PVA-NFs against E.coli 
and S.aureus. 
5.6. Conclusion 
AITC/β-CD-IC-PVA-NFs were produced via electrospinning. The 
characterizations were performed by SEM, XRD, and TGA. SEM images 
demonstrated that the morphology of PVA nanofibers did not change after the 
incorporation of AITC/β-CD-IC. In addition; owing to IC between AITC and β-
CD, the release of AITC from AITC/β-CD-IC-PVA-NFs was significantly 
higher than AITC-PVA-NFs. The antibacterial activity of AITC/β-CD-IC-PVA-
NFs against E.coli and S.aureus was 97.62% and 99.19%, respectively. Finally, 
both sustained release and quite high antibacterial activity of AITC/β-CD-IC-
PVA-NFs enable it to be used in wound dressing applications. 
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CHAPTER V. RELEASE of QUERCETIN from 
ELECTROSPUN POLYACRYLIC ACID NANOFIBERS 
INCORPORATING CYCLODEXTRIN INCLUSION 
COMPLEX 
 
6.1. General Information  
The polymeric drug delivery systems have advantages such as improving 
therapeutic effect and convenience, and reducing toxicity; while they might 
cause burst release of drugs and low efficiency in drug delivery [78]. 
Electrospinning is a simple and cost-effective method for producing nanofibers 
with high surface area to volume ratio and nanoporous structure [5]. Owing to 
these unique properties electrospun nanofibers is of importance in wound 
dressing, drug delivery systems and tissue engineering scaffolds [101]. 
Cyclodextrins (CDs) are cyclic oligosaccharides with truncated cone shape 
structure. They have relatively hydrophobic cavity that allows formation of 
inclusion complex (IC) with a variety of molecules in appropriate polarity and 
dimension. ICs of CDs are favorable because they might exhibit higher 
solubility and thermal stability of hydrophobic guests; controlling volatility, 
masking off unpleasant odors, and controlled release of drugs and flavors [38].  
In this study, IC of quercetin (QU) (Figure 44a) and beta-cyclodextrin (β-
CD) (Figure 44b, 44c) was formed (QU/β-CD-IC) at 1:1 molar ratio. The 
schematic representation of QU/β-CD-IC was shown in Figure 44d. Then QU/β-
CD-IC incorporating polyacrylic acid (PAA) nanofibers (QU/β-CD-IC-PAA-
NFs) were produced via electrospinning. QU/β-CD-IC including PAA films 
(QU/β-CD-IC-PAA films) was also produced as control. Obtained films and 
nanofibers were thermally crosslinked at 140°C for 40 minutes, and insoluble 
films and nanofibers were obtained. The characterizations were performed by 
scanning electron microscopy (SEM), X-ray diffraction (XRD) and 
thermogravimetric analysis (TGA). The release of QU into phosphate buffer 
saline (PBS) including methanol and tween 20 (PBMT) from QU/β-CD-IC-
PAA-films and QU/β-CD-IC-PAA-NFs were determined via high performance 
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liquid chromatography (HPLC). In addition, the antioxidant activity was 
investigated through UV-Vis NIR spectroscopy.  
 
Figure 44. Chemical structure of (a) QU, (b) β-CD; schematic representation of 
(c) β-CD, and (d) QU/β-CD-IC.   
6.2. Materials 
Polyacrylic acid (PAA, Mw ~ 450.000 g/mol, Sigma aldrich), beta-
cyclodextrin (β-CD) (Wacker chemie AG, Germany), quercetin (QU, Sigma 
aldrich, ≥98%), methanol (Sigma aldrich, extra pure), ethanol (Sigma aldrich, 
99.8%),  methanol chromasolv (Sigma aldrich), potassium phosphate monobasic 
(Riedel de haen), disodium hydrogen phosphate 12-hydrate (Riedel de haen), 
sodium chloride (Sigma aldrich), tween 20 (Sigma aldrich), 2,2-diphenyl-1-
picrylhydrazyl (DPPH, Sigma aldrich)  were purchased and used as-received 
without any further purification. Distilled water was supplied from Millipore 
Milli-Q Ultrapure Water System. 
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6.3. Production of films and electrospun nanofibers 
QU/β-CD-IC-PAA-films and QU/β-CD-IC-PAA-NFs were produced via 
solvent casting method and electrospinning, respectively. The molar ratio of 
QU:β-CD was 1:1 for both of the samples. For preparation of QU/β-CD-IC-
PAA-films, QU was dissolved in aqueous solution. Then, β-CD was added and 
the solution was stirred for 12 hours at room temperature. Finally, PAA (7.5% 
(w/v)) was added and the solution was stirred 4 hours more. Films were 
prepared from as-prepared solutions by casting them onto glass petri dish; as the 
solvent evaporates, films were formed in petri dish. In order to produce QU/β-
CD-IC-PAA-NFs; initially, QU was dissolved in aqueous solution for 0.5 hours; 
after the addition of β-CD, the solution was stirred for 12 hours at room 
temperature. Lastly, PAA (7.5% (w/v)) was added and stirred 4 hours more. The 
resulting solution loaded into 3 ml plastic syringe with a needle inner diameter 
of 0.8 mm were placed horizontally on the pump and sent towards to the 
collector at 1 ml/h rate. 15 kV was obtained from a high voltage power supply. 
Cylindrical metal covered with aluminum foil was used as a collector. Distance 
between needle tip and collector was 15 cm. Experiments were performed at 
23°C-26°C, 17%-18% humidity. Finally, QU/β-CD-IC-PAA-films and QU/β-
CD-IC-PAA-NFs were thermally crosslinked at 140°C for 40 minutes in 
vacuum drying oven. Here, we think that hydroxyl groups of β-CD and carboxyl 
groups of PAA was crosslinked and insoluble QU/β-CD-IC-PAA-films and 
QU/β-CD-IC-PAA-NFs were obtained. 
6.4. Preparation of phosphate buffer 
 
For the preparation of PBS, 1.44 g potassium phosphate monobasic, 10.74 
g disodium hydrogen phosphate 12-hydrate and 90 g sodium chloride were 
dissolved in 1000 ml of distilled water. Then, this solution was diluted with 
distilled water at the rate of 1:9. 10% methanol and 0.5% tween 20 were added 
into PBS to increase the solubility of α-TC in the releasing medium and lastly 
PBMT was obtained. pH of the releasing media was measured as about 7. 
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6.5. Drug release assay 
Total immersion method was used to investigate the cumulative release 
proﬁles of QU from QU/β-CD-IC-PAA-films and QU/β-CD-IC-PAA-NFs. The 
films and nanofibers were immersed in 30 ml of PBMT at 37°C, stirred at 50 
rpm for 360 minutes. 0.5 ml of the test medium was withdrawn and an equal 
amount of the fresh medium was reﬁlled. The amount of released QU was 
measured via HPLC equipped with VWD UV detector. The calibration samples 
were prepared by dissolving QU in PBMT. The concentration of QU was 
calculated to determine the cumulative amount of QU released from the samples 
at each speciﬁed immersion period. The experiments were performed in 
triplicate and the results were reported as average values±standard deviation. 
6.6. Measurements and characterization techniques 
The morphologies and average fiber diameters (AFDs) of QU/β-CD-IC-
PAA-NFs before and after crosslink were examined by SEM (FEI – Quanta 200 
FEG). Before taking SEM images, samples were coated 5 nm Au/Pd. In order to 
calculate AFDs, around 100 fibers were analyzed.  
XRD data for QU, PAA, β-CD, QU/β-CD-IC-PAA-films and QU/β-CD-
IC-PAA-NFs were recorded using a PANalytical X’Pert powder diﬀractometer 
applying Cu Kα radiation in a 2θ range 5°–30°. 
In order to investigate the thermal stability of QU in the electrospun 
nanoﬁbers; QU/β-CD-IC-PAA-NFs were assessed via TGA (Q 500, TA 
Instruments, USA). QU, PAA, β-CD and QU/β-CD-IC-PAA-films were also 
tested for comparison. The measurements were carried out under nitrogen 
atmosphere, the samples were heated up to 600°C at a constant heating rate of 
20°C/min. 
Amount of released QU from QU/β-CD-IC-PAA-films and QU/β-CD-IC-
PAA-NFs were measured using HPLC (Agilient, 1200 series) equipped with 
VWD UV detector. The column used was a 250 mm×4.6 mm i.d., 5μm, Inertisil 
GL Sciences Inc. diol column and the detection was accomplished at 375 nm. 
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Mobile phase, flow rate, injection volume and total run time were 100% 
methanol, 1 ml/min, 20 µl and 7 minutes, respectively. 
Antioxidant tests for QU/β-CD-IC-PAA-films and QU/β-CD-IC-PAA-
NFs were performed via DPPH radical scavenging assay. 10
-4
 M DPPH solution 
was prepared in ethanol/water (50:50); and 2 mg nanofibers were dissolved in 
ethanol. Then, 0.5 ml of nanofibers solution was added on 2.5 ml of DPPH 
solution. The resulting mixture was remained in the dark for 15 minutes at room 
temperature. At the end of the 15 minutes, the absorbance of the solutions was 
measured with UV-Vis NIR Spectroscopy (Varian Cary 5000) at 517 nm.  
6.7. Results and discussion 
PAA is an anionic polyelectrolyte and amorphous polymer [134]. 
Electrospinning of PAA was studied by many groups [37, 135-136]. In addition, 
there are also studies on bioapplications of PAA [36, 137].  On the other hand, 
QU is an antioxidant flavonoid and a hydrophobic compound. It is a widely used 
substance especially for bioapplications [138]. There exist many studies in the 
literature about IC of QU with CDs [105, 139-141].  Furthermore, IC of QU and 
CDs were incorporated in polymeric films. In these studies CDs used for 
controlled release or acted as protective compound against oxidation of QU 
[107-108]. Here, we produced QU/β-CD-IC-PAA-NFs through electrospinning 
in order to combine high surface area to volume ratio and nanoporous structure 
of electrospun nanofibers with high solubility of QU/β-CD-IC. 
The SEM images and AFD distributions of QU/β-CD-IC-PAA-NFs 
before crosslink were shown in Figure 45. We observed that uniform nanofibers 
were obtained from 7.5% (w/v) polymer concentration in aqueous solution 
(Figure 45). In addition, QU molecules were dispersed homogenously inside the 
nanofiber. Therefore, we might deduce that QU molecules were inside the 
nanofibers due to the rapid evaporation of solvent molecules during 
electrospinning. Similar results were observed in a study in which four different 
kinds of drugs were encapsulated in electrospun cellulose acetate nanofibers 
[79]. We calculated AFD of QU/β-CD-IC-PAA-NFs as 805±185 nm.  
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Figure 45. SEM images and AFD distributions of QU/β-CD-IC-PAA-NFs 
before crosslink. 
Moreover, SEM image of QU/β-CD-IC-PAA-NFs after crosslink was 
shown in Figure 46. As seen from the SEM image nanofibers kept their fiber 
structure after crosslink. 
20 μm
 
Figure 46. SEM images of QU/β-CD-IC-PAA-NFs after crosslink. 
The XRD patterns of QU, PAA, β-CD, QU/β-CD-IC-PAA-films and 
QU/β-CD-IC-PAA-NFs were displayed in Figure 47. QU is a highly crystalline 
compound with sharp diffraction peaks. This result was supported by a study 
about QU loaded nanoparticles from the literature [142]. On the other side, PAA 
has an amorphous nature with broad diffraction peak as stated in a study that is 
on synthesizing PAA-metal nanocomposites [143]. In the XRD pattern of QU/β-
CD-IC-PAA-films, we observed some of the diffraction peaks (2θ=5.56°, 
10.98°, 13.58°, 16.53°) those belong to QU. This might show that there existed 
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uncomplexed QU molecules inside the films. The XRD pattern of QU/β-CD-IC-
PAA-NFs showed broad halo diffraction pattern with a distinct diffraction peak 
at 2θ=13.58°. This result showed that QU/β-CD-IC-PAA-NFs were mostly 
amorphous. In addition, the diffraction peak at 2θ=13.58° showed the presence 
of some uncomplexed free QU inside the nanofibers. On the other hand; when 
β-CD forms IC with a guest molecule, the cage type packing of β-CD turns into 
channel type packing (2θ=12° and 18°) [132]. We could not observe channel 
type packing of β-CD in XRD pattern of QU/β-CD-IC-PAA-NFs, so we could 
not deduce that there was IC formation between QU and β-CD or not.   
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Figure 47. XRD patterns of (a) QU, (b) PAA, (c) βCD, (d) QU/β-CD-IC-PAA 
films, (e) QU/β-CD-IC-PAA-NFs. 
The thermal stability of QU, PAA, β-CD, QU/β-CD-IC-PAA-films, and 
QU/β-CD-IC-PAA-NFs were investigated by TGA (Figure 48). The thermal 
degradation of QU started at around 280°C and this was consistent with the 
literature investigating solid dispersions of QU and a polymer [144]. The 
thermal degradation of PAA occurred in three steps. The first degradation was 
between 190-290°C, second degradation was between 290-350°C; whereas the 
third degradation which was the main thermal degradation started at around 
420°C. This was also observed in the literature concerning PAA doped 
polyaniline [145]. β-CD had two steps of thermal degradation. The first one is 
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water loss that is up to 100°C and the second one is its main thermal degradation 
and above 275°C [112]. QU/β-CD-IC-PAA-films exhibited three stages during 
its thermal degradation. The first degradation which started at around 200°C 
ascribed to the first thermal degradation of PAA, the second one attributed to 
thermal degradation of β-CD, QU and PAA and started at about 250°C; finally, 
the last one started at about 360°C and belonged to the main thermal 
degradation of PAA. Similarly, QU/β-CD-IC-PAA-NFs had three steps of 
thermal degradation. These degradation points started at around 220°C, 280°C, 
360°C and attributed to thermal degradations of PAA; β-CD, QU and PAA; and 
PAA respectively. In brief, we could not observe any improvement in the 
thermal stability of QU; therefore we cannot state that there is an IC formation 
between QU and β-CD or not.  Similarly, in the study of Koontz et al. the 
improvement could not be achieved for QU/gamma-cyclodextrin (γ-CD)-IC as 
well [105]. 
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Figure 48. TGA thermograms of (a) QU, (b) PAA, (c) βCD, (d) QU/β-CD-IC-
PAA films, (e) QU/β-CD-IC-PAA-NFs. 
The release experiments for QU/β-CD-IC-PAA-films and QU/β-CD-IC-
PAA-NFs were performed in PBMT at 37°C for 360 minutes. The concentration 
of released QU versus time was shown in Figure 49. Zero-order release kinetic 
was observed for QU/β-CD-IC-PAA-films and QU/β-CD-IC-PAA-NFs. We can 
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divide into two stages the release behavior of QU from both of the samples. QU 
released relatively quickly in the first stage; then the release rate became 
constant. 
QU is a hydrophobic compound, so it is not soluble in PBS. That’s why 
we added methanol and tween 20 into PBS in order to increase dissolution and 
facilitate detection of QU. It is not soluble in polymer solution as well. 
Therefore, its interaction with polymer was not strong. This was also observed 
between another drug molecule and polymer in the literature [113]. Briefly, we 
expected QU to release rapidly in the first stage. On the other hand, we know 
that presence of another molecule in the solution reduces the diffusion rate 
[108]. So, the existence of QU/β-CD-IC reduced the diffusion coefficient and 
release rate of QU from QU/β-CD-IC-PAA-films and QU/β-CD-IC-PAA-NFs. 
QU/β-CD-IC-PAA-films released 24±3 ppm QU; while QU/β-CD-IC-PAA-NFs 
released 21±6 ppm in the initial stage. In general nanofibers exhibit higher 
release rate than films due to their high surface area to volume ratio and porous 
structure at nanoscale as reported in the literature [146]. In our case, 
uncomplexed QU molecules might be responsible from relatively higher release 
rate of films compared with nanofibers at the initial stage. Lastly, the released 
amount of QU was almost same for QU/β-CD-IC-PAA films and QU/β-CD-IC-
PAA-NFs. As a result, we successfully achieved to produce controlled release of 
QU from QU/β-CD-IC-PAA-NFs. 
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Figure 49. Cumulative release proﬁles of (a) QU/β-CD-IC-PAA-films, (b) 
QU/β-CD-IC-PAA-NFs. 
The antioxidant activity of QU in QU/β-CD-IC-PAA-films and QU/β-
CD-IC-PAA-NFs were examined through DPPH radical scavenging assay. The 
results were shown in Figure 50.  DPPH is a stable free radical in violet color. It 
is commonly used for testing antioxidant activity of antioxidant molecules. In 
radical scavenging mechanism, antioxidant molecule is a hydrogen donor that 
transforms DPPH radical into its reduced form; therefore, its radical character is 
neutralized and color turns into pale yellow. As DPPH has an absorbance at 517 
nm, antioxidant activity of various molecules could be measured 
spectrophotometrically [117]. From the reduction in the absorbance of DPPH 
containing solutions at 517 nm, the antioxidant activity was calculated according 
to following formula: 
 
where AB is the absorption of the blank and AS is the absorption of the sample 
[118]. The antioxidant activity of QU/β-CD-IC-PAA-films and QU/β-CD-IC-
PAA-NFs were 17% and 82%, respectively. Although we applied high electrical 
potential on QU/β-CD-IC-PAA-NFs during electrospinning process, we 
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observed that QU maintained its antioxidant activity in QU/β-CD-IC-PAA-NFs, 
even it was much higher than QU/β-CD-IC-PAA films. In a study on shikonin 
loaded electrospun composite nanofibers, antioxidant activity of shikonin did 
not change much after electrospinning as well [114]. Secondly, the much better 
antioxidant activity of nanofibers compared to films was basically related with 
high surface area to volume ratio of nanofibers. Similar results were also 
observed in the literature about antioxidant property of polyaniline nanofibers. 
Thus, high surface area increases the availability of reaction sites and improves 
the antioxidant activity [118]. We also observed the changing in the color of 
solution that is violet in the beginning of the experiment turned into pale yellow 
at the end of experiment for QU/β-CD-IC-PAA-NFs [118]. 
 
Figure 50. UV-vis spectrum of (a) DPPH, (b) QU/β-CD-IC-PAA-films 
including DPPH solution, (c) QU/β-CD-IC-PAA-NFs including DPPH solution. 
6.8. Conclusion 
We successfully produced QU/β-CD-IC-PAA-NFs. Then obtained 
nanofibers were crosslinked thermally without using any chemical. The 
structural and thermal characterizations of nanofibers were carried out by SEM, 
XRD, and TGA. Controlled release was achieved for QU/β-CD-IC-PAA-NFs  
and QU/β-CD-IC-PAA films both of the samples. However, the release of QU 
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from QU/β-CD-IC-PAA-NFs was slower than QU/β-CD-IC-PAA films at the 
initial stage. QU/β-CD-IC-PAA-NFs exhibited quite high antioxidant activity 
which was 65% more than QU/β-CD-IC-PAA films. As a result, QU/β-CD-IC-
PAA-NFs could be used in the release of QU with high antioxidant activity. 
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CHAPTER VI. 
CONCLUSION 
 
In this thesis study, we produced cyclodextrin (CD) functionalized 
electrospun nanofibers. In the first part, we electrospun hydroxypropyl cellulose 
(HPC), carboxymethyl cellulose (CMC) and alginate-based nanofibers. In 
addition, we produced functional electrospun nanofibers from incorporating CD 
HPC, CMC and alginate nanofibers. These functional electrospun nanofibers 
have both unique properties of electrospun nanofibers like high surface area to 
volume ratio, porous structure at nanoscale, and ability of CD molecules to form 
inclusion complex with many compounds. Hence, they could be used in 
biomedical applications such as drug delivery, wound healing and tissue 
engineering. 
In the second part, inclusion complex (IC) of sulfisoxazole (SFS) and 
hydroxypropyl-beta-cyclodextrin (HPβCD) (SFS/HPβCD-IC) incorporating 
hydroxypropyl cellulose (HPC) nanofibers were produced via electrospinning 
(SFS/HPβCD-IC-HPC-NFs).  The structural and thermal characterizations were 
done by scanning electron microscopy (SEM), X-ray diffraction (XRD), 
differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA). 
The controlled release of SFS was attained with higher release compared to SFS 
without HPβ-CD including HPC nanofibers. This is related with higher 
solubility of SFS/HPβ-CD-IC. 
In the third part of thesis study, IC of α-tocopherol (α-TC) and beta-
cyclodextrin (β-CD) (α-TC/β-CD-IC) was produced, and polycaprolactone 
(PCL) nanofibers incorporating α-TC/β-CD-IC was obtained by electrospinning 
(α-TC/β-CD-PCL-NFs). SEM, XRD, DSC and TGA were employed to 
characterize α-TC/β-CD-PCL-NFs. Controlled release was observed from α-
TC/β-CD-PCL-NFs. In addition, α-TC/β-CD-PCL-NFs had higher 
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photostability and antioxidant activity than α-TC without β-CD including PCL 
nanofibers. 
In the fourth part, we prepared IC of allyl isothiocyanate (AITC) and β-
CD (AITC/β-CD-IC), and then AITC/β-CD-IC including polyvinyl alcohol 
(PVA) solution was electrospun (AITC/β-CD-IC-PVA-NFs). The structural and 
thermal characterizations of AITC/β-CD-IC-PVA-NFs were performed by SEM, 
XRD, and TGA. The amount of released AITC from AITC/β-CD-IC-PVA-NFs 
were considerably higher compared with AITC without β-CD including PVA 
nanofibers due to the inclusion complex between AITC and β-CD. Moreover, 
AITC/β-CD-IC-PVA-NFs showed quite high antibacterial activity against 
Escherichia coli (E.coli) and Staphylococcus aureus (S.aureus). 
In the fifth part, IC of quercetin (QU) and β-CD (QU/β-CD-IC) 
incorporating polyacrylic acid (PAA) nanofibers was produced by 
electrospinning (QU/β-CD-IC-PAA-NFs). SEM, XRD, and TGA were the 
methods that we used to characterize QU/β-CD-IC-PAA-NFs. The release of 
QU from QU/β-CD-IC-PAA-NFs was slower and more controlled manner; 
whereas the antioxidant activity was significantly higher as compared to QU/β-
CD-IC including films. 
In brief, we produced CD and CD-IC functionalized biocompatible 
polymeric nanofibers (SFS/HPβCD-IC-HPC-NFs, α-TC/β-CD-PCL-NFs, 
AITC/β-CD-IC-PVA-NFs and QU/β-CD-IC-PAA-NFs) by electrospinning. 
These nanofibers can be used in drug delivery, wound healing and tissue 
engineering applications. We will continue our studies by incorporating another 
types of drug-CD-ICs into various polymers. 
 
 
 
 
86 
 
REFERENCES 
[1] S. Ramakrishna, An introduction to electrospinning and nanofibers, World 
Scientific Pub Co Inc, 2005. 
[2] D. Li and Y. Xia, Advanced Materials 2004, 16, 1151-1170. 
[3] S. Ramakrishna, K. Fujihara, W. E. Teo, T. Yong, Z. Ma and R. 
Ramaseshan, Materials Today 2006, 9, 40-50. 
[4] X. Lu, C. Wang and Y. Wei, Small 2009, 5, 2349-2370. 
[5] A. Greiner and J. H. Wendorff, Angewandte Chemie International Edition 
2007, 46, 5670-5703. 
[6] J. F. Cooley, US 692, 631, 1902. 
[7] W. J. Morton, US 705, 691, 1902. 
[8] J. F. Cooley, US 745, 276, 1903 
[9]. A. Formhals, US 1, 975, 504, 1934. 
[10]. W. Simm, K. Gosling, R. Bonart, B. von Falkai, GB 1346231,1972. 
[11] J. Doshi and D. H. Reneker, Journal of electrostatics 1995, 35, 151-160. 
[12] G. Srinivasan and D. H. Reneker, Polymer international 1995, 36, 195-201. 
[13]. A. E.Zachariades, R. S. Porter, J. Doshi, G. Srinivasan, D.H. Reneker,  
Polymer News 1995, 20 (7), 206-207  
[14] C. Wang, H. S. Chien, C. H. Hsu, Y. C. Wang, C. T. Wang and H. A. Lu, 
Macromolecules 2007, 40, 7973-7983. 
[15] G. T. Kim, J. S. Lee, J. H. Shin, Y. C. Ahn, Y. J. Hwang, H. S. Shin, J. K. 
Lee and C. M. Sung, Korean Journal of Chemical Engineering 2005, 22, 783-
788. 
[16] V. Thavasi, G. Singh and S. Ramakrishna, Energy Environ. Sci. 2008, 1, 
205-221. 
87 
 
[17] T. J. Sill and H. A. Von Recum, Biomaterials 2008, 29, 1989-2006. 
[18] P. Zahedi, I. Rezaeian, S. O. Ranaei‐Siadat, S. H. Jafari and P. Supaphol, 
Polymers for Advanced Technologies 2010, 21, 77-95. 
[19]. Biopolymers: making materials nature’s way, Washington, DC: U.S. 
Government Printing Office, September 1993 
[20] J. D. Schiffman and C. L. Schauer, Polymer Reviews 2008, 48, 317-352.  
[21] M. J. John and S. Thomas, Carbohydrate Polymers 2008, 71, 343-364. 
[22]. J.H. Gu, G.W. Skinner, W.W. Harcum, P.E. Barnum, PSTT 1998, 1,  254-
261. 
[23] A. C. Stijnman, I. Bodnar and R. Hans Tromp, Food Hydrocolloids 2011. 
[24] A. Mohanty, M. Misra and G. Hinrichsen, Macromolecular Materials and 
Engineering 2000, 276, 1-24. 
[25] S. Sinha Ray and M. Bousmina, Progress in Materials Science 2005, 50, 
962-1079. 
[26] A. Cipitria, A. Skelton, T. Dargaville, P. Dalton and D. Hutmacher, J. 
Mater. Chem. 2011, 21, 9419-9453. 
[27]. S.H. Bahrami, A.G. Kanani, Journal of Nanomaterials 2010, art. no. 
724153 
[28] H. Jiang, Y. Hu, Y. Li, P. Zhao, K. Zhu and W. Chen, Journal of 
Controlled Release 2005, 108, 237-243. 
[29] E. Luong-Van, L. Grøndahl, K. N. Chua, K. W. Leong, V. Nurcombe and 
S. M. Cool, Biomaterials 2006, 27, 2042-2050. 
[30] Z. M. Huang, C. L. He, A. Yang, Y. Zhang, X. J. Han, J. Yin and Q. Wu, 
Journal of Biomedical Materials Research Part A 2006, 77, 169-179. 
[31] E. R. Kenawy, F. I. Abdel-Hay, M. H. El-Newehy and G. E. Wnek, 
Materials Chemistry and Physics 2009, 113, 296-302. 
88 
 
[32] J. Zeng, A. Aigner, F. Czubayko, T. Kissel, J. H. Wendorff and A. Greiner, 
Biomacromolecules 2005, 6, 1484-1488. 
[33] P. Taepaiboon, U. Rungsardthong and P. Supaphol, Nanotechnology 2006, 
17, 2317. 
[34] E. R. Kenawy, F. I. Abdel-Hay, M. H. El-Newehy and G. E. Wnek, 
Materials Science and Engineering: A 2007, 459, 390-396. 
[35] N. Charernsriwilaiwat, P. Opanasopit, T. Rojanarata, T. Ngawhirunpat and 
P. Supaphol, Carbohydrate Polymers 2010, 81, 675-680. 
[36]. A. Chunder, S. Sarkar, Y. Yu, L. Zhai, Colloids and Surfaces B: 
Biointerfaces 2007, 58, 172–179 
[37] X. Shen, D. Yu, L. Zhu and C. Branford-White, 2010, pp. 1-4. 
[38] E. M. Del Valle, Process Biochemistry 2004, 39, 1033-1046. 
[39] J. Szejtli, Chemical Reviews 1998, 98, 1743-1754. 
[40] J. Szejtli, J. Mater. Chem. 1997, 7, 575-587. 
[41] M. Majzoobi, R. Ostovan and A. Farahnaky, Journal of Texture Studies 
2011, 42, 20-30. 
[42] J. Johnson, J. Holinej and M. Williams, International journal of 
pharmaceutics 1993, 90, 151-159. 
[43] T. Fukuyama, S. Sato, Y. Fukase and K. Ito, Dental materials journal 
2010, 29, 160-166. 
[44] S. Shukla, E. Brinley, H. J. Cho and S. Seal, Polymer 2005, 46, 12130-
12145. 
[45] L. Francis, A. Balakrishnan, K. Sanosh and E. Marsano, Materials Letters 
2010, 64, 1806-1808. 
[46] A. Frenot, M. W. Henriksson and P. Walkenström, Journal of applied 
polymer science 2007, 103, 1473-1482. 
[47] L. Xie, Z. Q. Shao and S. Y. Lv, Applied Mechanics and Materials 2012, 
130, 1266-1269. 
[48] J. Song, N. L. Birbach and J. P. Hinestroza, Cellulose 2012, 1-14. 
[49] A. Steinbüchel and S. K. Rhee, Polysaccharides and polyamides in the food 
industry, Wiley-VCH, 2005. 
89 
 
[50] H. Nie, A. He, J. Zheng, S. Xu, J. Li and C. C. Han, Biomacromolecules 
2008, 9, 1362-1365. 
[51] N. Bhattarai, Z. Li, D. Edmondson and M. Zhang, Advanced Materials 
2006, 18, 1463-1467. 
[52] J. W. Lu, Y. L. Zhu, Z. X. Guo, P. Hu and J. Yu, Polymer 2006, 47, 8026-
8031. 
[53] S. Safi, M. Morshed, S. Hosseini Ravandi and M. Ghiaci, Journal of 
applied polymer science 2007, 104, 3245-3255. 
[54] N. Bhattarai and M. Zhang, Nanotechnology 2007, 18, 455601.  
[55] S. C. Moon, B. Y. Ryu, J. K. Choi, B. W. Jo and R. J. Farris, Polymer 
Engineering & Science 2009, 49, 52-59. 
[56] Q. S. Kong, Z. S. Yu, Q. Ji and Y. Z. Xia, Advanced Drug Delivery 
Reviews 2009, pp. 1188-1191. 
[57] H. Nie, A. He, W. Wu, J. Zheng, S. Xu, J. Li and C. C. Han, Polymer 2009, 
50, 4926-4934. 
[58] G. H. Kim and K. Park, Polymer Engineering & Science 2009, 49, 2242-
2248. 
[59]. S.I. Jeong, M.D. Krebs, C.A. Bonino,  S .A. Khan,  E. Alsberg, 
Macromolecular Bioscience 2010  10 (8) , 934-943  
[60] S. A. Park, K. E. Park and W. D. Kim, Macromolecular Research 2010, 18, 
891-896. 
[61] S. I. Jeong, M. D. Krebs, C. A. Bonino, J. E. Samorezov, S. A. Khan and E. 
Alsberg, Tissue Engineering Part A 2010, 17, 59-70. 
[62] S. H. Huang, T. C. Chien and K. Y. Hung, Current Nanoscience 2011, 7, 
267-274. 
[63] C. A. Bonino, M. D. Krebs, C. D. Saquing, S. I. Jeong, K. L. Shearer, E. 
Alsberg and S. A. Khan, Carbohydrate Polymers 2011. 
[64] C. A. Bonino, K. Efimenko, S. I. Jeong, M. D. Krebs, E. Alsberg and S. A. 
Khan, Small 2012. 
90 
 
[65] Y. J. Lee, D. S. Shin, O. W. Kwon, W. H. Park, H. G. Choi, Y. R. Lee, S. 
S. Han, S. K. Noh and W. S. Lyoo, Journal of applied polymer science 2007, 
106, 1337-1342. 
[66]. M.S. Islam, M.R. Karim, Colloids and Surfaces A: Physicochem. Eng. 
Aspects 2010, 366, 135–140 
[67] K. Tarun and N. Gobia, Indian Journal of Fibre & Textile Research 2012, 
37, 127-132. 
[68] K. Shalumon, K. Anulekha, S. V. Nair, K. Chennazhi and R. Jayakumar, 
International journal of biological macromolecules 2011. 
[69] D. Fang, Y. Liu, S. Jiang, J. Nie and G. Ma, Carbohydrate Polymers 2011. 
[70] T. Uyar, A. Balan, L. Toppare and F. Besenbacher, Polymer 2009, 50, 475-
480. 
[71] T. Uyar, R. Havelund, Y. Nur, J. Hacaloglu, F. Besenbacher and P. 
Kingshott, Journal of Membrane Science 2009, 332, 129-137. 
[72] T. Uyar, R. Havelund, J. Hacaloglu, X. Zhou, F. Besenbacher and P. 
Kingshott, Nanotechnology 2009, 20, 125605. 
[73] T. Uyar, R. Havelund, J. Hacaloglu, F. Besenbacher and P. Kingshott, ACS 
nano 2010. 
[74] T. Uyar, R. Havelund, Y. Nur, A. Balan, J. Hacaloglu, L. Toppare, F. 
Besenbacher and P. Kingshott, Journal of Membrane Science 2010, 365, 409-
417. 
[75] F. Kayaci and T. Uyar, Carbohydrate Polymers 2012. 
[76] F. Kayaci and T. Uyar, Food Chemistry 2012. 
[77] C. G. Park, E. Kim, M. Park, J. H. Park, Y. B. Choy, Journal of Controlled 
Release 2011, 149, 250–257 
[78] J. Zeng, X. Xu, X. Chen, Q. Liang, X. Bian, L. Yang and X. Jing, Journal 
of Controlled Release 2003, 92, 227-231. 
[79] S. Tungprapa, I. Jangchud and P. Supaphol, Polymer 2007, 48, 5030-5041. 
[80] A. Martins, A. R. C. Duarte, S. Faria, A. P. Marques, R. L. Reis and N. M. 
Neves, Biomaterials 2010, 31, 5875-5885. 
91 
 
[81] E. R. Kenawy, G. L. Bowlin, K. Mansfield, J. Layman, D. G. Simpson, E. 
H. Sanders and G. E. Wnek, Journal of Controlled Release 2002, 81, 57-64. 
[82] S. Suganya, T. Senthil Ram, B. Lakshmi and V. Giridev, Journal of applied 
polymer science 2011. 
[83] S. Maretschek, A. Greiner and T. Kissel, Journal of Controlled Release 
2008, 127, 180-187. 
[84] I. Liao, S. Chen, J. B. Liu and K. W. Leong, Journal of Controlled Release 
2009, 139, 48-55. 
[85] L. Szente and J. Szejtli, Advanced drug delivery reviews 1999, 36, 17-28. 
[86] L. Ghasemi-Mobarakeh, M. P. Prabhakaran, M. Morshed, M. H. Nasr-
Esfahani and S. Ramakrishna, Biomaterials 2008, 29, 4532-4539. 
[87] E. Chong, T. Phan, I. Lim, Y. Zhang, B. Bay, S. Ramakrishna and C. Lim, 
Acta biomaterialia 2007, 3, 321-330. 
[88] G. Y. Y. J. S. Xiaofeng and Z. M. C. Zhinan, Progress in Chemistry 2009, 
Z2. 
[89] A. A. Muthu Prabhu, G. Venkatesh and N. Rajendiran, Journal of solution 
chemistry 2010, 39, 1061-1086. 
[90] G. Gladys, G. Claudia and L. Marcela, European journal of pharmaceutical 
sciences 2003, 20, 285-293. 
[91] A. Wei, J. Wang, X. Wang, Q. Wei, M. Ge and D. Hou, Journal of applied 
polymer science 2010, 118, 346-352. 
[92] C. Wang, H. Tan, Y. Dong and Z. Shao, Reactive and Functional Polymers 
2006, 66, 1165-1173. 
[93] X. Y. Li, X. Wang, D. G. Yu, S. Ye, Q. K. Kuang, Q. W. Yi and X. Z. Yao, 
Journal of Nanomaterials 2012, 2012, 7. 
[94] A. Celebioglu and T. Uyar, Langmuir 2011. 
[95] J. Panichpakdee and P. Supaphol, Carbohydrate Polymers 2011. 
[96] G. Maa, Y. Liua, C. Penga, D. Fanga, B. Hec, J. Niea, Carbohydrate 
Polymers 2011,  86, 505–512. 
[97] D. C. Bibby, N. M. Davies and I. G. Tucker, International journal of 
pharmaceutics 2000, 197, 1-11. 
92 
 
[98] K. Kim, Y. K. Luu, C. Chang, D. Fang, B. S. Hsiao, B. Chu and M. 
Hadjiargyrou, Journal of Controlled Release 2004, 98, 47-56. 
[99] Q. Wang, Z. Dong, Y. Du and J. F. Kennedy, Carbohydrate Polymers 
2007, 69, 336-343. 
[100] J. Szejtli, Cyclodextrin Technology, Chionin Pharmaceutical – chemical 
works, Budapest, Hungary, Kluwer, the language of science, 1988, 188-191, 337 
[101] C. Burger, B. S. Hsiao and B. Chu, Annu. Rev. Mater. Res. 2006, 36, 333-
368. 
[102] J. Szejtli and L. Szente, European journal of pharmaceutics and 
biopharmaceutics 2005, 61, 115-125. 
[103] C. K. Liu, N. P. Latona and M. Ramos, Journal of applied polymer 
science 2011. 
[104] A. Iaconinoto, M. Chicca, S. Pinamonti, A. Casolari, A. Bianchi and S. 
Scalia, Die Pharmazie-An International Journal of Pharmaceutical Sciences 
2004, 59, 30-33. 
[105] A. Iaconinoto, M. Chicca, S. Pinamonti, A. Casolari, A. Bianchi and S. 
Scalia, Die Pharmazie-An International Journal of Pharmaceutical Sciences 
2004, 59, 30-33. 
[106] I. Siró, É. Fenyvesi, L. Szente, B. De Meulenaer, F. Devlieghere, J. 
Orgoványi, J. Sényi and J. Barta, Food additives and contaminants 2006, 23, 
845-853. 
[107] J. L. Koontz, J. E. Marcy, S. F. O'Keefe, S. E. Duncan, T. E. Long and R. 
D. Moffitt, Journal of applied polymer science 2010, 117, 2299-2309. 
[108] J. Koontz, R. Moffitt, J. Marcy, S. O’Keefe, S. Duncan and T. Long, Food 
additives and contaminants 2010, 27, 1598-1607. 
[109] T. Uyar, Y. Nur, J. Hacaloglu and F. Besenbacher, Nanotechnology 2009, 
20, 125703. 
93 
 
[110] S. Arora, R. Bagoria and M. Kumar, Journal of thermal analysis and 
calorimetry 2010, 102, 375-381. 
[111] B. A. Allo, A. S. Rizkalla and K. Mequanint, Langmuir 2010. 
[112] L. Cunha-Silva and J. J. C. Teixeira-Dias, New J. Chem. 2004, 28, 200-
206.  
[113] M. V. Natu, H. C. De Sousa and M. Gil, International journal of 
pharmaceutics 2010, 397, 50-58. 
[114] J. Han, T. X. Chen, C. J. Branford-White and L. M. Zhu, International 
journal of pharmaceutics 2009, 382, 215-221. 
[115] C. M. Sabliov, C. Fronczek, C. Astete, M. Khachaturyan, L. Khachatryan 
and C. Leonardi, Journal of the American Oil Chemists' Society 2009, 86, 895-
902. 
[116]. P.M. Bramley, I. Elmadfa, A. Kafatos, J.F. Kelly, Y. Manios, H.E. 
Roxborough, W. Schuch, P.J.A. Sheehy, K.H. Wagner,  J Sci Food Agric. 2000, 
80, 913-938 
[117] J. K. Moon and T. Shibamoto, Journal of agricultural and Food 
Chemistry 2009, 57, 1655-1666. 
[118] S. Banerjee, J. P. Saikia, A. Kumar and B. Konwar, Nanotechnology 2010, 
21, 045101. 
[119] C. Jullian, C. Cifuentes, M. Alfaro, S. Miranda, G. Barriga and C. Olea-
Azar, Bioorganic & medicinal chemistry 2010, 18, 5025-5031. 
[120] J. Li, M. Zhang, J. Chao and S. Shuang, Spectrochimica Acta Part A: 
Molecular and Biomolecular Spectroscopy 2009, 73, 752-756. 
[121] M. M. Fir, L. Milivojevic, M. Prosek and A. Smidovnik, Acta chimica 
slovenica 2009, 56, 885-891. 
94 
 
[122] K. Shalumon, N. Binulal, N. Selvamurugan, S. Nair, D. Menon, T. 
Furuike, H. Tamura and R. Jayakumar, Carbohydrate Polymers 2009, 77, 863-
869.  
[123] Y. Zhou, D. Yang, X. Chen, Q. Xu, F. Lu and J. Nie, Biomacromolecules 
2007, 9, 349-354. 
[124] Q. F. Zhang, Z. T. Jiang and R. Li, European Food Research and 
Technology 2007, 225, 407-413. 
[125] X. Li, Z. Jin and J. Wang, Food Chemistry 2007, 103, 461-466. 
[126] S. Hayashi, E. Nakamura, Y. Kubo, N. Takahashi, A. Yamaguchi, H. 
Matsui, S. Hagen and K. Takeuchi, Acta physiologica Polonica 2008, 59, 691. 
[127] S. Hayashi, E. Nakamura, T. Endo, Y. Kubo and K. Takeuchi, 
Inflammopharmacology 2007, 15, 218-222. 
[128] D. Plackett, A. Ghanbari Siahkali and L. Szente, Journal of applied 
polymer science 2007, 105, 2850-2857. 
[129] A. C. Vega-Lugo and L. T. Lim, Food Research International 2009, 42, 
933-940. 
[130] Y. Ohta, K. Takatani and S. Kawakishi, Bioscience, biotechnology, and 
biochemistry 2000, 64, 190-193. 
[131] J. H. Park, H. W. Lee, D. K. Chae, W. Oh, J. D. Yun, Y. Deng and J. H. 
Yeum, Colloid & Polymer Science 2009, 287, 943-950. 
[132] C. C. Rusa, T. A. Bullions, J. Fox, F. E. Porbeni, X. Wang and A. E. 
Tonelli, Langmuir 2002, 18, 10016-10023. 
[133] M. Ignatova, Z. Petkova, N. Manolova, N. Markova and I. Rashkov, 
Macromolecular bioscience 2012. 
[134] S. Xiao, M. Shen, H. Ma, R. Guo, M. Zhu, S. Wang and X. Shi, Journal of 
applied polymer science 2010, 116, 2409-2417. 
[135]. H. Jing, Y. Jiang, X. Du,, Proceedings of SPIE - The International 
Society for Optical Engineering 2010, art. no. 76584B  
95 
 
[136] S. Theron, E. Zussman and A. Yarin, Polymer 2004, 45, 2017-2030. 
[137] K. McKeon Fischer, D. Flagg and J. Freeman, Journal of Biomedical 
Materials Research Part A 2011. 
[138]. Rice-Evans, C., Free Radical Biology and Medicine 2004, 36 (7) , 827-
828  
[139] T. Pralhad and K. Rajendrakumar, Journal of pharmaceutical and 
biomedical analysis 2004, 34, 333-339.  
[140] Y. Zheng, I. S. Haworth, Z. Zuo, M. S. S. Chow and A. H. L. Chow, 
Journal of pharmaceutical sciences 2005, 94, 1079-1089. 
[141] C. Jullian, L. Moyano, C. Yanez and C. Olea-Azar, Spectrochimica Acta 
Part A: Molecular and Biomolecular Spectroscopy 2007, 67, 230-234. 
[142] T. H. Wu, F. L. Yen, L. T. Lin, T. R. Tsai, C. C. Lin and T. M. Cham, 
International journal of pharmaceutics 2008, 346, 160-168. 
[143] X. Xu, Y. Yin, X. Ge, H. Wu and Z. Zhang, Materials Letters 1998, 37, 
354-358. 
[144] Y. L. Li, Y. Yang, T. C. Bai and J. J. Zhu, Journal of Chemical & 
Engineering Data 2010. 
[145] X. Lu, C. Y. Tan, J. Xu and C. He, Synthetic metals 2003, 138, 429-440. 
[146] P. Thitiwongsawet and P. Supaphol, Polymers for Advanced Technologies 
2011, 22, 1366-1374. 
 
